| ENSG00000172965.10 |
Gemcitabine |
Bladder urothelial carcinoma |
0.02199103 |
Resistant |
| ENSG00000177757.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.002687933 |
Resistant |
| ENSG00000186594.8 |
Gemcitabine |
Bladder urothelial carcinoma |
0.013363981 |
Resistant |
| ENSG00000189223.9 |
Gemcitabine |
Bladder urothelial carcinoma |
0.039369848 |
Resistant |
| ENSG00000203325.3 |
Gemcitabine |
Bladder urothelial carcinoma |
0.031675855 |
Resistant |
| ENSG00000212552.2 |
Gemcitabine |
Bladder urothelial carcinoma |
0.010084183 |
Resistant |
| ENSG00000222041.6 |
Gemcitabine |
Bladder urothelial carcinoma |
0.026597827 |
Resistant |
| ENSG00000224271.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.010568023 |
Resistant |
| ENSG00000224635.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.049074482 |
Resistant |
| ENSG00000224855.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.049602425 |
Resistant |
| ENSG00000227195.4 |
Gemcitabine |
Bladder urothelial carcinoma |
0.031352148 |
Resistant |
| ENSG00000227456.3 |
Gemcitabine |
Bladder urothelial carcinoma |
0.042929231 |
Resistant |
| ENSG00000228140.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.027961072 |
Resistant |
| ENSG00000231595.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.049411859 |
Resistant |
| ENSG00000232139.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.018402949 |
Resistant |
| ENSG00000232533.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.020688258 |
Resistant |
| ENSG00000232739.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.036083797 |
Resistant |
| ENSG00000233825.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.038992058 |
Resistant |
| ENSG00000236671.3 |
Gemcitabine |
Bladder urothelial carcinoma |
0.033946954 |
Resistant |
| ENSG00000236850.4 |
Gemcitabine |
Bladder urothelial carcinoma |
0.013511133 |
Resistant |
| ENSG00000237689.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.027166354 |
Resistant |
| ENSG00000238045.5 |
Gemcitabine |
Bladder urothelial carcinoma |
0.034634164 |
Resistant |
| ENSG00000238280.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.022776519 |
Resistant |
| ENSG00000239445.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.049127706 |
Resistant |
| ENSG00000239653.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.04855174 |
Resistant |
| ENSG00000240453.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.001503499 |
Resistant |
| ENSG00000243701.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.01244887 |
Resistant |
| ENSG00000243944.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.019183833 |
Resistant |
| ENSG00000247809.3 |
Gemcitabine |
Bladder urothelial carcinoma |
0.02571946 |
Resistant |
| ENSG00000249252.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.021999997 |
Resistant |
| ENSG00000250410.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.024033451 |
Resistant |
| ENSG00000253476.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.017529071 |
Resistant |
| ENSG00000253829.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.028650749 |
Resistant |
| ENSG00000253837.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.004110155 |
Resistant |
| ENSG00000253986.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.018385357 |
Resistant |
| ENSG00000254428.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.02934535 |
Resistant |
| ENSG00000256050.2 |
Gemcitabine |
Bladder urothelial carcinoma |
0.01533191 |
Resistant |
| ENSG00000257496.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.005381185 |
Resistant |
| ENSG00000258086.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.012575306 |
Resistant |
| ENSG00000258260.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.035275928 |
Resistant |
| ENSG00000258303.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.045495296 |
Resistant |
| ENSG00000258592.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.026382652 |
Resistant |
| ENSG00000258858.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.008808177 |
Resistant |
| ENSG00000258891.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.034975752 |
Resistant |
| ENSG00000258959.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.008036088 |
Resistant |
| ENSG00000259118.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.036308516 |
Resistant |
| ENSG00000259402.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.049271336 |
Resistant |
| ENSG00000259652.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.035202626 |
Resistant |
| ENSG00000260025.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.038692981 |
Resistant |
| ENSG00000260141.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.038659808 |
Resistant |
| ENSG00000260352.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.02186575 |
Resistant |
| ENSG00000260367.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.032886967 |
Resistant |
| ENSG00000260626.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.026238116 |
Resistant |
| ENSG00000260955.2 |
Gemcitabine |
Bladder urothelial carcinoma |
0.013727561 |
Resistant |
| ENSG00000261471.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.036316065 |
Resistant |
| ENSG00000261476.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.019779391 |
Resistant |
| ENSG00000262686.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.047976573 |
Resistant |
| ENSG00000262777.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.026539707 |
Resistant |
| ENSG00000265656.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.028508095 |
Resistant |
| ENSG00000267201.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.049062339 |
Resistant |
| ENSG00000267568.2 |
Gemcitabine |
Bladder urothelial carcinoma |
0.038592192 |
Resistant |
| ENSG00000268364.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.035933441 |
Resistant |
| ENSG00000269352.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.035933395 |
Resistant |
| ENSG00000269720.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.044759172 |
Resistant |
| ENSG00000269903.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.032634188 |
Resistant |
| ENSG00000270061.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.011464924 |
Resistant |
| ENSG00000270095.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.026752038 |
Resistant |
| ENSG00000270103.2 |
Gemcitabine |
Bladder urothelial carcinoma |
0.011631879 |
Resistant |
| ENSG00000271734.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.008503723 |
Resistant |
| ENSG00000272181.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.043323265 |
Resistant |
| ENSG00000272273.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.018173529 |
Resistant |
| ENSG00000272379.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.0305897 |
Resistant |
| ENSG00000272650.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.041888548 |
Resistant |
| ENSG00000273038.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.020774819 |
Resistant |
| ENSG00000273243.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.018969656 |
Resistant |
| ENSG00000273353.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.018873737 |
Resistant |
| ENSG00000118412.8 |
Gemcitabine |
Breast invasive carcinoma |
0.006560448 |
Resistant |
| ENSG00000179406.6 |
Gemcitabine |
Breast invasive carcinoma |
0.031241968 |
Resistant |
| ENSG00000203801.4 |
Gemcitabine |
Breast invasive carcinoma |
0.015411093 |
Resistant |
| ENSG00000204055.4 |
Gemcitabine |
Breast invasive carcinoma |
0.031173186 |
Resistant |
| ENSG00000215039.2 |
Gemcitabine |
Breast invasive carcinoma |
0.043775044 |
Resistant |
| ENSG00000223652.2 |
Gemcitabine |
Breast invasive carcinoma |
0.041377545 |
Resistant |
| ENSG00000223745.3 |
Gemcitabine |
Breast invasive carcinoma |
0.03993967 |
Resistant |
| ENSG00000225076.1 |
Gemcitabine |
Breast invasive carcinoma |
0.019320564 |
Resistant |
| ENSG00000225112.1 |
Gemcitabine |
Breast invasive carcinoma |
0.035939176 |
Resistant |
| ENSG00000225138.3 |
Gemcitabine |
Breast invasive carcinoma |
0.002263583 |
Resistant |
| ENSG00000225140.1 |
Gemcitabine |
Breast invasive carcinoma |
0.024080367 |
Resistant |
| ENSG00000225331.1 |
Gemcitabine |
Breast invasive carcinoma |
0.0425292 |
Resistant |
| ENSG00000225760.1 |
Gemcitabine |
Breast invasive carcinoma |
0.045713813 |
Resistant |
| ENSG00000226890.1 |
Gemcitabine |
Breast invasive carcinoma |
0.04080231 |
Resistant |
| ENSG00000226913.1 |
Gemcitabine |
Breast invasive carcinoma |
0.049262781 |
Resistant |
| ENSG00000227188.1 |
Gemcitabine |
Breast invasive carcinoma |
0.020980675 |
Resistant |
| ENSG00000228133.2 |
Gemcitabine |
Breast invasive carcinoma |
0.014522095 |
Resistant |
| ENSG00000228677.1 |
Gemcitabine |
Breast invasive carcinoma |
0.015165668 |
Resistant |
| ENSG00000230184.1 |
Gemcitabine |
Breast invasive carcinoma |
0.040203737 |
Resistant |
| ENSG00000231977.1 |
Gemcitabine |
Breast invasive carcinoma |
0.049486711 |
Resistant |
| ENSG00000232519.2 |
Gemcitabine |
Breast invasive carcinoma |
0.048119846 |
Resistant |
| ENSG00000232732.5 |
Gemcitabine |
Breast invasive carcinoma |
0.045035271 |
Resistant |
| ENSG00000233427.1 |
Gemcitabine |
Breast invasive carcinoma |
0.04294632 |
Resistant |
| ENSG00000234091.1 |
Gemcitabine |
Breast invasive carcinoma |
0.040113385 |
Resistant |
| ENSG00000234141.1 |
Gemcitabine |
Breast invasive carcinoma |
0.045260911 |
Resistant |
| ENSG00000234183.1 |
Gemcitabine |
Breast invasive carcinoma |
0.021555277 |
Resistant |
| ENSG00000234437.1 |
Gemcitabine |
Breast invasive carcinoma |
0.026959633 |
Resistant |
| ENSG00000235085.2 |
Gemcitabine |
Breast invasive carcinoma |
0.013583325 |
Resistant |
| ENSG00000235262.1 |
Gemcitabine |
Breast invasive carcinoma |
0.045809336 |
Resistant |
| ENSG00000236896.1 |
Gemcitabine |
Breast invasive carcinoma |
0.039153323 |
Resistant |
| ENSG00000237423.1 |
Gemcitabine |
Breast invasive carcinoma |
0.027402357 |
Resistant |
| ENSG00000237689.1 |
Gemcitabine |
Breast invasive carcinoma |
0.014263906 |
Resistant |
| ENSG00000238184.1 |
Gemcitabine |
Breast invasive carcinoma |
0.009609566 |
Resistant |
| ENSG00000239002.2 |
Gemcitabine |
Breast invasive carcinoma |
0.030652969 |
Resistant |
| ENSG00000246859.2 |
Gemcitabine |
Breast invasive carcinoma |
0.042698559 |
Resistant |
| ENSG00000247853.2 |
Gemcitabine |
Breast invasive carcinoma |
0.001416853 |
Resistant |
| ENSG00000248714.2 |
Gemcitabine |
Breast invasive carcinoma |
0.013253455 |
Resistant |
| ENSG00000249532.2 |
Gemcitabine |
Breast invasive carcinoma |
0.012676977 |
Resistant |
| ENSG00000250234.1 |
Gemcitabine |
Breast invasive carcinoma |
0.02933225 |
Resistant |
| ENSG00000253865.1 |
Gemcitabine |
Breast invasive carcinoma |
0.040301753 |
Resistant |
| ENSG00000253955.1 |
Gemcitabine |
Breast invasive carcinoma |
0.008470832 |
Resistant |
| ENSG00000254458.1 |
Gemcitabine |
Breast invasive carcinoma |
0.033716371 |
Resistant |
| ENSG00000255129.1 |
Gemcitabine |
Breast invasive carcinoma |
0.013396199 |
Resistant |
| ENSG00000255343.1 |
Gemcitabine |
Breast invasive carcinoma |
0.012245435 |
Resistant |
| ENSG00000255471.1 |
Gemcitabine |
Breast invasive carcinoma |
0.021945528 |
Resistant |
| ENSG00000255970.1 |
Gemcitabine |
Breast invasive carcinoma |
0.036325816 |
Resistant |
| ENSG00000256195.2 |
Gemcitabine |
Breast invasive carcinoma |
0.043991581 |
Resistant |
| ENSG00000256199.1 |
Gemcitabine |
Breast invasive carcinoma |
0.031955404 |
Resistant |
| ENSG00000257279.1 |
Gemcitabine |
Breast invasive carcinoma |
0.027770965 |
Resistant |
| ENSG00000258137.1 |
Gemcitabine |
Breast invasive carcinoma |
0.047947495 |
Resistant |
| ENSG00000258458.1 |
Gemcitabine |
Breast invasive carcinoma |
0.031987571 |
Resistant |
| ENSG00000258620.1 |
Gemcitabine |
Breast invasive carcinoma |
0.013447068 |
Resistant |
| ENSG00000258922.1 |
Gemcitabine |
Breast invasive carcinoma |
0.041272039 |
Resistant |
| ENSG00000258935.1 |
Gemcitabine |
Breast invasive carcinoma |
0.011741415 |
Resistant |
| ENSG00000258999.1 |
Gemcitabine |
Breast invasive carcinoma |
0.036612772 |
Resistant |
| ENSG00000259103.1 |
Gemcitabine |
Breast invasive carcinoma |
0.026939513 |
Resistant |
| ENSG00000259163.1 |
Gemcitabine |
Breast invasive carcinoma |
0.038517911 |
Resistant |
| ENSG00000259606.2 |
Gemcitabine |
Breast invasive carcinoma |
0.04198767 |
Resistant |
| ENSG00000259820.1 |
Gemcitabine |
Breast invasive carcinoma |
0.03899439 |
Resistant |
| ENSG00000259891.1 |
Gemcitabine |
Breast invasive carcinoma |
0.016283299 |
Resistant |
| ENSG00000259899.1 |
Gemcitabine |
Breast invasive carcinoma |
0.041066178 |
Resistant |
| ENSG00000260526.1 |
Gemcitabine |
Breast invasive carcinoma |
0.029665096 |
Resistant |
| ENSG00000260545.1 |
Gemcitabine |
Breast invasive carcinoma |
0.037353323 |
Resistant |
| ENSG00000260625.1 |
Gemcitabine |
Breast invasive carcinoma |
0.047189299 |
Resistant |
| ENSG00000260693.1 |
Gemcitabine |
Breast invasive carcinoma |
0.006495462 |
Resistant |
| ENSG00000260796.1 |
Gemcitabine |
Breast invasive carcinoma |
0.026522957 |
Resistant |
| ENSG00000260911.1 |
Gemcitabine |
Breast invasive carcinoma |
0.032237394 |
Resistant |
| ENSG00000261043.2 |
Gemcitabine |
Breast invasive carcinoma |
0.030417037 |
Resistant |
| ENSG00000261101.1 |
Gemcitabine |
Breast invasive carcinoma |
0.041735541 |
Resistant |
| ENSG00000261280.2 |
Gemcitabine |
Breast invasive carcinoma |
0.009512139 |
Resistant |
| ENSG00000261496.1 |
Gemcitabine |
Breast invasive carcinoma |
0.033683792 |
Resistant |
| ENSG00000261574.1 |
Gemcitabine |
Breast invasive carcinoma |
0.017842743 |
Resistant |
| ENSG00000261801.1 |
Gemcitabine |
Breast invasive carcinoma |
0.039660283 |
Resistant |
| ENSG00000262117.1 |
Gemcitabine |
Breast invasive carcinoma |
0.037283295 |
Resistant |
| ENSG00000262445.3 |
Gemcitabine |
Breast invasive carcinoma |
0.011539303 |
Resistant |
| ENSG00000262869.1 |
Gemcitabine |
Breast invasive carcinoma |
0.028240011 |
Resistant |
| ENSG00000263120.1 |
Gemcitabine |
Breast invasive carcinoma |
0.028240646 |
Resistant |
| ENSG00000265342.1 |
Gemcitabine |
Breast invasive carcinoma |
0.046872759 |
Resistant |
| ENSG00000266261.1 |
Gemcitabine |
Breast invasive carcinoma |
0.018542853 |
Resistant |
| ENSG00000267143.1 |
Gemcitabine |
Breast invasive carcinoma |
0.03589331 |
Resistant |
| ENSG00000267144.1 |
Gemcitabine |
Breast invasive carcinoma |
0.044184685 |
Resistant |
| ENSG00000268199.2 |
Gemcitabine |
Breast invasive carcinoma |
0.040940301 |
Resistant |
| ENSG00000269463.1 |
Gemcitabine |
Breast invasive carcinoma |
0.013670835 |
Resistant |
| ENSG00000269836.1 |
Gemcitabine |
Breast invasive carcinoma |
0.035702422 |
Resistant |
| ENSG00000269976.1 |
Gemcitabine |
Breast invasive carcinoma |
0.041217556 |
Resistant |
| ENSG00000270562.1 |
Gemcitabine |
Breast invasive carcinoma |
0.011986245 |
Resistant |
| ENSG00000270951.1 |
Gemcitabine |
Breast invasive carcinoma |
0.016727442 |
Resistant |
| ENSG00000271009.2 |
Gemcitabine |
Breast invasive carcinoma |
0.007587198 |
Resistant |
| ENSG00000271430.1 |
Gemcitabine |
Breast invasive carcinoma |
0.03692052 |
Resistant |
| ENSG00000271555.1 |
Gemcitabine |
Breast invasive carcinoma |
0.035258865 |
Resistant |
| ENSG00000272250.1 |
Gemcitabine |
Breast invasive carcinoma |
0.012304018 |
Resistant |
| ENSG00000272942.1 |
Gemcitabine |
Breast invasive carcinoma |
0.032043701 |
Resistant |
| ENSG00000273338.1 |
Gemcitabine |
Breast invasive carcinoma |
0.040627624 |
Resistant |
| ENSG00000175699.8 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.022599621 |
Resistant |
| ENSG00000196756.7 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.02979346 |
Resistant |
| ENSG00000223393.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.021805999 |
Resistant |
| ENSG00000223935.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040975755 |
Resistant |
| ENSG00000226007.2 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.043750419 |
Resistant |
| ENSG00000227279.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031969445 |
Resistant |
| ENSG00000227533.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045195249 |
Resistant |
| ENSG00000230850.3 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017939159 |
Resistant |
| ENSG00000231196.3 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.00317821 |
Resistant |
| ENSG00000232907.3 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013695087 |
Resistant |
| ENSG00000234232.2 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.024254996 |
Resistant |
| ENSG00000234705.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032746014 |
Resistant |
| ENSG00000234943.2 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.046011669 |
Resistant |
| ENSG00000236209.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.023893609 |
Resistant |
| ENSG00000240057.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013119875 |
Resistant |
| ENSG00000242391.2 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.004877901 |
Resistant |
| ENSG00000244198.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.01373903 |
Resistant |
| ENSG00000244479.2 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.027952102 |
Resistant |
| ENSG00000251562.3 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.048178218 |
Resistant |
| ENSG00000253112.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045941148 |
Resistant |
| ENSG00000254484.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035681719 |
Resistant |
| ENSG00000255045.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.01195741 |
Resistant |
| ENSG00000257337.2 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039503665 |
Resistant |
| ENSG00000260941.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03567633 |
Resistant |
| ENSG00000261068.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035257987 |
Resistant |
| ENSG00000261485.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.026058834 |
Resistant |
| ENSG00000261644.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03312838 |
Resistant |
| ENSG00000262319.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.008490319 |
Resistant |
| ENSG00000262979.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.016180142 |
Resistant |
| ENSG00000263923.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038077176 |
Resistant |
| ENSG00000265451.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.014090462 |
Resistant |
| ENSG00000265479.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042520948 |
Resistant |
| ENSG00000266965.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04016945 |
Resistant |
| ENSG00000267481.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.007373039 |
Resistant |
| ENSG00000269172.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.01410753 |
Resistant |
| ENSG00000270761.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.009296932 |
Resistant |
| ENSG00000271855.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.007654418 |
Resistant |
| ENSG00000272457.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04875724 |
Resistant |
| ENSG00000272791.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032019638 |
Resistant |
| ENSG00000272796.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015029009 |
Resistant |
| ENSG00000177788.5 |
Gemcitabine |
Colon adenocarcinoma |
0.017654288 |
Resistant |
| ENSG00000219665.4 |
Gemcitabine |
Colon adenocarcinoma |
0.011786855 |
Resistant |
| ENSG00000223839.3 |
Gemcitabine |
Colon adenocarcinoma |
0.045289358 |
Resistant |
| ENSG00000225439.2 |
Gemcitabine |
Colon adenocarcinoma |
0.022907479 |
Resistant |
| ENSG00000225975.2 |
Gemcitabine |
Colon adenocarcinoma |
0.027400271 |
Resistant |
| ENSG00000226266.2 |
Gemcitabine |
Colon adenocarcinoma |
0.021278179 |
Resistant |
| ENSG00000226562.2 |
Gemcitabine |
Colon adenocarcinoma |
0.035129226 |
Resistant |
| ENSG00000228395.1 |
Gemcitabine |
Colon adenocarcinoma |
0.034747953 |
Resistant |
| ENSG00000232645.1 |
Gemcitabine |
Colon adenocarcinoma |
0.014670565 |
Resistant |
| ENSG00000233230.1 |
Gemcitabine |
Colon adenocarcinoma |
0.003244257 |
Resistant |
| ENSG00000233509.2 |
Gemcitabine |
Colon adenocarcinoma |
0.04427815 |
Resistant |
| ENSG00000233799.1 |
Gemcitabine |
Colon adenocarcinoma |
0.006439121 |
Resistant |
| ENSG00000234380.1 |
Gemcitabine |
Colon adenocarcinoma |
0.047542662 |
Resistant |
| ENSG00000236514.1 |
Gemcitabine |
Colon adenocarcinoma |
0.016340268 |
Resistant |
| ENSG00000239377.1 |
Gemcitabine |
Colon adenocarcinoma |
0.001596387 |
Resistant |
| ENSG00000239569.2 |
Gemcitabine |
Colon adenocarcinoma |
0.011717898 |
Resistant |
| ENSG00000240449.1 |
Gemcitabine |
Colon adenocarcinoma |
0.046868904 |
Resistant |
| ENSG00000241472.2 |
Gemcitabine |
Colon adenocarcinoma |
0.041506348 |
Resistant |
| ENSG00000245060.2 |
Gemcitabine |
Colon adenocarcinoma |
0.019515379 |
Resistant |
| ENSG00000247970.2 |
Gemcitabine |
Colon adenocarcinoma |
0.003185417 |
Resistant |
| ENSG00000253948.1 |
Gemcitabine |
Colon adenocarcinoma |
0.045796965 |
Resistant |
| ENSG00000254615.2 |
Gemcitabine |
Colon adenocarcinoma |
0.020038644 |
Resistant |
| ENSG00000254777.1 |
Gemcitabine |
Colon adenocarcinoma |
0.048692316 |
Resistant |
| ENSG00000256458.1 |
Gemcitabine |
Colon adenocarcinoma |
0.037393272 |
Resistant |
| ENSG00000259818.1 |
Gemcitabine |
Colon adenocarcinoma |
0.003224244 |
Resistant |
| ENSG00000260219.1 |
Gemcitabine |
Colon adenocarcinoma |
0.049986058 |
Resistant |
| ENSG00000260360.1 |
Gemcitabine |
Colon adenocarcinoma |
0.000983682 |
Resistant |
| ENSG00000260572.1 |
Gemcitabine |
Colon adenocarcinoma |
0.01383882 |
Resistant |
| ENSG00000261242.1 |
Gemcitabine |
Colon adenocarcinoma |
0.005653418 |
Resistant |
| ENSG00000261693.1 |
Gemcitabine |
Colon adenocarcinoma |
0.019623882 |
Resistant |
| ENSG00000261824.2 |
Gemcitabine |
Colon adenocarcinoma |
0.034132521 |
Resistant |
| ENSG00000263011.1 |
Gemcitabine |
Colon adenocarcinoma |
0.002603511 |
Resistant |
| ENSG00000264575.1 |
Gemcitabine |
Colon adenocarcinoma |
0.038231363 |
Resistant |
| ENSG00000265091.1 |
Gemcitabine |
Colon adenocarcinoma |
0.025260328 |
Resistant |
| ENSG00000265625.1 |
Gemcitabine |
Colon adenocarcinoma |
0.016498669 |
Resistant |
| ENSG00000266921.1 |
Gemcitabine |
Colon adenocarcinoma |
0.001779291 |
Resistant |
| ENSG00000267194.1 |
Gemcitabine |
Colon adenocarcinoma |
0.012194006 |
Resistant |
| ENSG00000267898.1 |
Gemcitabine |
Colon adenocarcinoma |
0.040460961 |
Resistant |
| ENSG00000267939.1 |
Gemcitabine |
Colon adenocarcinoma |
0.003573083 |
Resistant |
| ENSG00000269293.2 |
Gemcitabine |
Colon adenocarcinoma |
0.001188163 |
Resistant |
| ENSG00000269560.1 |
Gemcitabine |
Colon adenocarcinoma |
0.004241292 |
Resistant |
| ENSG00000269843.1 |
Gemcitabine |
Colon adenocarcinoma |
0.040028077 |
Resistant |
| ENSG00000270571.2 |
Gemcitabine |
Colon adenocarcinoma |
0.001828765 |
Resistant |
| ENSG00000271855.1 |
Gemcitabine |
Colon adenocarcinoma |
0.01317047 |
Resistant |
| ENSG00000271966.1 |
Gemcitabine |
Colon adenocarcinoma |
0.045434805 |
Resistant |
| ENSG00000272091.1 |
Gemcitabine |
Colon adenocarcinoma |
0.043571156 |
Resistant |
| ENSG00000272103.1 |
Gemcitabine |
Colon adenocarcinoma |
0.026699536 |
Resistant |
| ENSG00000272248.1 |
Gemcitabine |
Colon adenocarcinoma |
0.017410962 |
Resistant |
| ENSG00000272250.1 |
Gemcitabine |
Colon adenocarcinoma |
0.041908006 |
Resistant |
| ENSG00000272444.1 |
Gemcitabine |
Colon adenocarcinoma |
0.0314585 |
Resistant |
| ENSG00000272691.1 |
Gemcitabine |
Colon adenocarcinoma |
0.043194147 |
Resistant |
| ENSG00000273008.1 |
Gemcitabine |
Colon adenocarcinoma |
0.0036099 |
Resistant |
| ENSG00000273035.1 |
Gemcitabine |
Colon adenocarcinoma |
0.012869336 |
Resistant |
| ENSG00000273456.1 |
Gemcitabine |
Colon adenocarcinoma |
0.003996951 |
Resistant |
| ENSG00000152487.6 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029837159 |
Resistant |
| ENSG00000204044.5 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041572033 |
Resistant |
| ENSG00000213793.3 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04112132 |
Resistant |
| ENSG00000214407.3 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028159861 |
Resistant |
| ENSG00000219665.4 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026068303 |
Resistant |
| ENSG00000223821.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031653654 |
Resistant |
| ENSG00000223901.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015080363 |
Resistant |
| ENSG00000224376.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02194615 |
Resistant |
| ENSG00000225187.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034945756 |
Resistant |
| ENSG00000225205.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014192925 |
Resistant |
| ENSG00000225836.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01487988 |
Resistant |
| ENSG00000228079.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043298257 |
Resistant |
| ENSG00000229111.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016672844 |
Resistant |
| ENSG00000230438.5 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048720825 |
Resistant |
| ENSG00000231025.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00501692 |
Resistant |
| ENSG00000231050.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00520113 |
Resistant |
| ENSG00000231393.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035326111 |
Resistant |
| ENSG00000231607.4 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004500301 |
Resistant |
| ENSG00000231789.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037962924 |
Resistant |
| ENSG00000231889.3 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005135508 |
Resistant |
| ENSG00000232648.3 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038958424 |
Resistant |
| ENSG00000232912.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003963186 |
Resistant |
| ENSG00000232936.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007839352 |
Resistant |
| ENSG00000233137.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005525881 |
Resistant |
| ENSG00000233665.4 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003495272 |
Resistant |
| ENSG00000233834.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028027718 |
Resistant |
| ENSG00000233864.3 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008807307 |
Resistant |
| ENSG00000235381.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008166959 |
Resistant |
| ENSG00000235590.3 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019160779 |
Resistant |
| ENSG00000236308.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035872129 |
Resistant |
| ENSG00000236519.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017582648 |
Resistant |
| ENSG00000236901.3 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001722308 |
Resistant |
| ENSG00000237021.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044352507 |
Resistant |
| ENSG00000237328.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008866965 |
Resistant |
| ENSG00000237436.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034512188 |
Resistant |
| ENSG00000237594.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012851834 |
Resistant |
| ENSG00000237976.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013036628 |
Resistant |
| ENSG00000238121.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015496727 |
Resistant |
| ENSG00000238140.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000673242 |
Resistant |
| ENSG00000240143.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023174325 |
Resistant |
| ENSG00000241280.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019683305 |
Resistant |
| ENSG00000242522.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023239058 |
Resistant |
| ENSG00000244124.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042936063 |
Resistant |
| ENSG00000244332.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005315579 |
Resistant |
| ENSG00000245812.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03729686 |
Resistant |
| ENSG00000246323.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017603068 |
Resistant |
| ENSG00000247774.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03311813 |
Resistant |
| ENSG00000248309.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015522618 |
Resistant |
| ENSG00000248367.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010968827 |
Resistant |
| ENSG00000248473.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016093861 |
Resistant |
| ENSG00000248559.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002730611 |
Resistant |
| ENSG00000248774.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016720794 |
Resistant |
| ENSG00000249655.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041194941 |
Resistant |
| ENSG00000250541.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02417315 |
Resistant |
| ENSG00000250988.3 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001338867 |
Resistant |
| ENSG00000251538.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023779268 |
Resistant |
| ENSG00000253174.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021719674 |
Resistant |
| ENSG00000253837.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001840754 |
Resistant |
| ENSG00000253865.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046558228 |
Resistant |
| ENSG00000254162.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043911885 |
Resistant |
| ENSG00000254343.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036789271 |
Resistant |
| ENSG00000254869.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04172176 |
Resistant |
| ENSG00000255421.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000228425 |
Resistant |
| ENSG00000255449.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012799586 |
Resistant |
| ENSG00000257815.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017459921 |
Resistant |
| ENSG00000258704.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004930277 |
Resistant |
| ENSG00000259209.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003696002 |
Resistant |
| ENSG00000259238.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015370653 |
Resistant |
| ENSG00000259768.3 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007980468 |
Resistant |
| ENSG00000259820.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011500435 |
Resistant |
| ENSG00000259901.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027071214 |
Resistant |
| ENSG00000259994.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004746374 |
Resistant |
| ENSG00000260177.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023441437 |
Resistant |
| ENSG00000260196.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001431567 |
Resistant |
| ENSG00000260260.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025998035 |
Resistant |
| ENSG00000260448.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03533701 |
Resistant |
| ENSG00000260589.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032812156 |
Resistant |
| ENSG00000260664.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021326711 |
Resistant |
| ENSG00000260924.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008699273 |
Resistant |
| ENSG00000261008.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024113824 |
Resistant |
| ENSG00000261218.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013552882 |
Resistant |
| ENSG00000261754.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047830165 |
Resistant |
| ENSG00000261879.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017061378 |
Resistant |
| ENSG00000262155.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026549877 |
Resistant |
| ENSG00000262222.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025466192 |
Resistant |
| ENSG00000262312.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032738193 |
Resistant |
| ENSG00000262514.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03136358 |
Resistant |
| ENSG00000263013.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026544845 |
Resistant |
| ENSG00000263331.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039628203 |
Resistant |
| ENSG00000263350.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014336428 |
Resistant |
| ENSG00000263499.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02656583 |
Resistant |
| ENSG00000263884.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02121518 |
Resistant |
| ENSG00000264270.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034221153 |
Resistant |
| ENSG00000264860.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02105022 |
Resistant |
| ENSG00000265342.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005399344 |
Resistant |
| ENSG00000266289.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01683049 |
Resistant |
| ENSG00000266983.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022534687 |
Resistant |
| ENSG00000267040.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028226969 |
Resistant |
| ENSG00000267108.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044406398 |
Resistant |
| ENSG00000267289.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043598313 |
Resistant |
| ENSG00000267787.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044487429 |
Resistant |
| ENSG00000267940.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027392819 |
Resistant |
| ENSG00000268289.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003815537 |
Resistant |
| ENSG00000268613.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021083395 |
Resistant |
| ENSG00000268649.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006084407 |
Resistant |
| ENSG00000268912.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025443209 |
Resistant |
| ENSG00000268970.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006207213 |
Resistant |
| ENSG00000269086.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043899257 |
Resistant |
| ENSG00000269290.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006065278 |
Resistant |
| ENSG00000269534.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004260007 |
Resistant |
| ENSG00000269653.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03706805 |
Resistant |
| ENSG00000269918.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043715656 |
Resistant |
| ENSG00000269942.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023104741 |
Resistant |
| ENSG00000269954.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018033103 |
Resistant |
| ENSG00000269974.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026044535 |
Resistant |
| ENSG00000270068.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016376837 |
Resistant |
| ENSG00000270137.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046938953 |
Resistant |
| ENSG00000271109.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040758139 |
Resistant |
| ENSG00000271856.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044227833 |
Resistant |
| ENSG00000272043.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026862967 |
Resistant |
| ENSG00000272219.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008062791 |
Resistant |
| ENSG00000272384.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022261338 |
Resistant |
| ENSG00000272446.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020854539 |
Resistant |
| ENSG00000272567.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046979034 |
Resistant |
| ENSG00000272689.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024378997 |
Resistant |
| ENSG00000272764.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037952181 |
Resistant |
| ENSG00000272853.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003775371 |
Resistant |
| ENSG00000273035.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04625709 |
Resistant |
| ENSG00000273156.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026293202 |
Resistant |
| ENSG00000273162.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001659049 |
Resistant |
| ENSG00000273373.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048453448 |
Resistant |
| ENSG00000273428.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024373398 |
Resistant |
| ENSG00000273449.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024262545 |
Resistant |
| ENSG00000273493.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021607037 |
Resistant |
| ENSG00000198468.3 |
Gemcitabine |
Esophageal cancer |
0.015009927 |
Resistant |
| ENSG00000204860.4 |
Gemcitabine |
Esophageal cancer |
0.045527037 |
Resistant |
| ENSG00000224764.1 |
Gemcitabine |
Esophageal cancer |
0.04848817 |
Resistant |
| ENSG00000224884.1 |
Gemcitabine |
Esophageal cancer |
0.032467572 |
Resistant |
| ENSG00000230423.1 |
Gemcitabine |
Esophageal cancer |
0.026953734 |
Resistant |
| ENSG00000233220.3 |
Gemcitabine |
Esophageal cancer |
0.045345959 |
Resistant |
| ENSG00000234880.1 |
Gemcitabine |
Esophageal cancer |
0.039074844 |
Resistant |
| ENSG00000253210.1 |
Gemcitabine |
Esophageal cancer |
0.008965048 |
Resistant |
| ENSG00000254162.1 |
Gemcitabine |
Esophageal cancer |
0.009844017 |
Resistant |
| ENSG00000254664.1 |
Gemcitabine |
Esophageal cancer |
0.00829293 |
Resistant |
| ENSG00000260447.1 |
Gemcitabine |
Esophageal cancer |
0.041412501 |
Resistant |
| ENSG00000262343.1 |
Gemcitabine |
Esophageal cancer |
0.025344242 |
Resistant |
| ENSG00000272498.1 |
Gemcitabine |
Esophageal cancer |
0.042499866 |
Resistant |
| ENSG00000223380.3 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.009019851 |
Resistant |
| ENSG00000226167.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.008742245 |
Resistant |
| ENSG00000228084.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.002802764 |
Resistant |
| ENSG00000230753.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.04006516 |
Resistant |
| ENSG00000231721.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.048423187 |
Resistant |
| ENSG00000232807.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.02636692 |
Resistant |
| ENSG00000249252.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.033038258 |
Resistant |
| ENSG00000253172.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.004044177 |
Resistant |
| ENSG00000253875.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.015529882 |
Resistant |
| ENSG00000254205.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.046607022 |
Resistant |
| ENSG00000254418.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.046655946 |
Resistant |
| ENSG00000254910.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.001335981 |
Resistant |
| ENSG00000255320.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.026244369 |
Resistant |
| ENSG00000257568.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.041777246 |
Resistant |
| ENSG00000257808.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.044920254 |
Resistant |
| ENSG00000258102.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.001025904 |
Resistant |
| ENSG00000259410.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.041481948 |
Resistant |
| ENSG00000260790.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.012290894 |
Resistant |
| ENSG00000260948.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.041237782 |
Resistant |
| ENSG00000267138.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.02320419 |
Resistant |
| ENSG00000267285.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.030097138 |
Resistant |
| ENSG00000267638.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.030587548 |
Resistant |
| ENSG00000267783.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.007112518 |
Resistant |
| ENSG00000268056.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.04260732 |
Resistant |
| ENSG00000268199.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.000353968 |
Resistant |
| ENSG00000271996.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.020612733 |
Resistant |
| ENSG00000272158.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.015260963 |
Resistant |
| ENSG00000273319.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.010481226 |
Resistant |
| ENSG00000179935.5 |
Gemcitabine |
Brain lower grade glioma |
0.028725775 |
Resistant |
| ENSG00000186019.10 |
Gemcitabine |
Brain lower grade glioma |
0.018553736 |
Resistant |
| ENSG00000205500.4 |
Gemcitabine |
Brain lower grade glioma |
0.049869314 |
Resistant |
| ENSG00000215039.2 |
Gemcitabine |
Brain lower grade glioma |
0.042583762 |
Resistant |
| ENSG00000215394.4 |
Gemcitabine |
Brain lower grade glioma |
0.035960158 |
Resistant |
| ENSG00000224875.2 |
Gemcitabine |
Brain lower grade glioma |
0.032851297 |
Resistant |
| ENSG00000224973.1 |
Gemcitabine |
Brain lower grade glioma |
0.033645665 |
Resistant |
| ENSG00000227136.2 |
Gemcitabine |
Brain lower grade glioma |
0.042983914 |
Resistant |
| ENSG00000227245.1 |
Gemcitabine |
Brain lower grade glioma |
0.043543366 |
Resistant |
| ENSG00000227403.1 |
Gemcitabine |
Brain lower grade glioma |
0.035646624 |
Resistant |
| ENSG00000227407.1 |
Gemcitabine |
Brain lower grade glioma |
0.024372412 |
Resistant |
| ENSG00000227518.2 |
Gemcitabine |
Brain lower grade glioma |
0.037481559 |
Resistant |
| ENSG00000228294.2 |
Gemcitabine |
Brain lower grade glioma |
0.034444368 |
Resistant |
| ENSG00000229723.1 |
Gemcitabine |
Brain lower grade glioma |
0.041348939 |
Resistant |
| ENSG00000229776.1 |
Gemcitabine |
Brain lower grade glioma |
0.045328184 |
Resistant |
| ENSG00000229955.1 |
Gemcitabine |
Brain lower grade glioma |
0.006160317 |
Resistant |
| ENSG00000230565.1 |
Gemcitabine |
Brain lower grade glioma |
0.03756444 |
Resistant |
| ENSG00000232300.1 |
Gemcitabine |
Brain lower grade glioma |
0.030504024 |
Resistant |
| ENSG00000232377.1 |
Gemcitabine |
Brain lower grade glioma |
0.036126409 |
Resistant |
| ENSG00000232564.1 |
Gemcitabine |
Brain lower grade glioma |
0.035774499 |
Resistant |
| ENSG00000233029.3 |
Gemcitabine |
Brain lower grade glioma |
0.039878048 |
Resistant |
| ENSG00000236434.2 |
Gemcitabine |
Brain lower grade glioma |
0.020258984 |
Resistant |
| ENSG00000239653.1 |
Gemcitabine |
Brain lower grade glioma |
0.025918213 |
Resistant |
| ENSG00000239677.2 |
Gemcitabine |
Brain lower grade glioma |
0.032282703 |
Resistant |
| ENSG00000241720.2 |
Gemcitabine |
Brain lower grade glioma |
0.03154057 |
Resistant |
| ENSG00000245112.2 |
Gemcitabine |
Brain lower grade glioma |
0.028390042 |
Resistant |
| ENSG00000247624.2 |
Gemcitabine |
Brain lower grade glioma |
0.043981839 |
Resistant |
| ENSG00000247982.2 |
Gemcitabine |
Brain lower grade glioma |
0.030965568 |
Resistant |
| ENSG00000248476.1 |
Gemcitabine |
Brain lower grade glioma |
0.031113624 |
Resistant |
| ENSG00000249293.1 |
Gemcitabine |
Brain lower grade glioma |
0.037609107 |
Resistant |
| ENSG00000249635.1 |
Gemcitabine |
Brain lower grade glioma |
0.031386136 |
Resistant |
| ENSG00000250692.1 |
Gemcitabine |
Brain lower grade glioma |
0.031389357 |
Resistant |
| ENSG00000251523.1 |
Gemcitabine |
Brain lower grade glioma |
0.02293493 |
Resistant |
| ENSG00000257568.1 |
Gemcitabine |
Brain lower grade glioma |
0.010015756 |
Resistant |
| ENSG00000258355.1 |
Gemcitabine |
Brain lower grade glioma |
0.042530071 |
Resistant |
| ENSG00000258553.1 |
Gemcitabine |
Brain lower grade glioma |
0.034437805 |
Resistant |
| ENSG00000258959.1 |
Gemcitabine |
Brain lower grade glioma |
0.049918348 |
Resistant |
| ENSG00000259298.1 |
Gemcitabine |
Brain lower grade glioma |
0.028351714 |
Resistant |
| ENSG00000259618.1 |
Gemcitabine |
Brain lower grade glioma |
0.041698022 |
Resistant |
| ENSG00000259876.1 |
Gemcitabine |
Brain lower grade glioma |
0.016663534 |
Resistant |
| ENSG00000260436.1 |
Gemcitabine |
Brain lower grade glioma |
0.020731594 |
Resistant |
| ENSG00000260545.1 |
Gemcitabine |
Brain lower grade glioma |
0.020373195 |
Resistant |
| ENSG00000260618.1 |
Gemcitabine |
Brain lower grade glioma |
0.049945585 |
Resistant |
| ENSG00000260905.1 |
Gemcitabine |
Brain lower grade glioma |
0.03482506 |
Resistant |
| ENSG00000260977.1 |
Gemcitabine |
Brain lower grade glioma |
0.041872091 |
Resistant |
| ENSG00000261131.1 |
Gemcitabine |
Brain lower grade glioma |
0.038205162 |
Resistant |
| ENSG00000261140.1 |
Gemcitabine |
Brain lower grade glioma |
0.046727543 |
Resistant |
| ENSG00000261187.1 |
Gemcitabine |
Brain lower grade glioma |
0.015800028 |
Resistant |
| ENSG00000261324.2 |
Gemcitabine |
Brain lower grade glioma |
0.024000947 |
Resistant |
| ENSG00000261396.1 |
Gemcitabine |
Brain lower grade glioma |
0.041042978 |
Resistant |
| ENSG00000263338.1 |
Gemcitabine |
Brain lower grade glioma |
0.030871082 |
Resistant |
| ENSG00000263924.1 |
Gemcitabine |
Brain lower grade glioma |
0.007540721 |
Resistant |
| ENSG00000265739.1 |
Gemcitabine |
Brain lower grade glioma |
0.018890333 |
Resistant |
| ENSG00000267006.1 |
Gemcitabine |
Brain lower grade glioma |
0.023583091 |
Resistant |
| ENSG00000267273.1 |
Gemcitabine |
Brain lower grade glioma |
0.046021068 |
Resistant |
| ENSG00000267491.1 |
Gemcitabine |
Brain lower grade glioma |
0.009194952 |
Resistant |
| ENSG00000267762.1 |
Gemcitabine |
Brain lower grade glioma |
0.044732382 |
Resistant |
| ENSG00000268093.1 |
Gemcitabine |
Brain lower grade glioma |
0.039371489 |
Resistant |
| ENSG00000268670.1 |
Gemcitabine |
Brain lower grade glioma |
0.04421217 |
Resistant |
| ENSG00000269194.1 |
Gemcitabine |
Brain lower grade glioma |
0.031580194 |
Resistant |
| ENSG00000269950.1 |
Gemcitabine |
Brain lower grade glioma |
0.026460363 |
Resistant |
| ENSG00000270130.1 |
Gemcitabine |
Brain lower grade glioma |
0.011952254 |
Resistant |
| ENSG00000270140.1 |
Gemcitabine |
Brain lower grade glioma |
0.049457767 |
Resistant |
| ENSG00000270876.1 |
Gemcitabine |
Brain lower grade glioma |
0.015559816 |
Resistant |
| ENSG00000271127.1 |
Gemcitabine |
Brain lower grade glioma |
0.037611853 |
Resistant |
| ENSG00000271259.1 |
Gemcitabine |
Brain lower grade glioma |
0.045841238 |
Resistant |
| ENSG00000271327.1 |
Gemcitabine |
Brain lower grade glioma |
0.031370831 |
Resistant |
| ENSG00000272033.1 |
Gemcitabine |
Brain lower grade glioma |
0.033273476 |
Resistant |
| ENSG00000272181.1 |
Gemcitabine |
Brain lower grade glioma |
0.041468038 |
Resistant |
| ENSG00000272862.1 |
Gemcitabine |
Brain lower grade glioma |
0.040146519 |
Resistant |
| ENSG00000272894.1 |
Gemcitabine |
Brain lower grade glioma |
0.004359652 |
Resistant |
| ENSG00000273402.1 |
Gemcitabine |
Brain lower grade glioma |
0.014884979 |
Resistant |
| ENSG00000178803.6 |
Gemcitabine |
Lung squamous cell carcinoma |
0.032914048 |
Resistant |
| ENSG00000179935.5 |
Gemcitabine |
Lung squamous cell carcinoma |
0.025693469 |
Resistant |
| ENSG00000181800.5 |
Gemcitabine |
Lung squamous cell carcinoma |
0.03636148 |
Resistant |
| ENSG00000189196.4 |
Gemcitabine |
Lung squamous cell carcinoma |
0.036990059 |
Resistant |
| ENSG00000203280.3 |
Gemcitabine |
Lung squamous cell carcinoma |
0.030802314 |
Resistant |
| ENSG00000214770.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.022794366 |
Resistant |
| ENSG00000216863.5 |
Gemcitabine |
Lung squamous cell carcinoma |
0.015334961 |
Resistant |
| ENSG00000223884.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.023989153 |
Resistant |
| ENSG00000224394.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.027238392 |
Resistant |
| ENSG00000224810.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.019840132 |
Resistant |
| ENSG00000224965.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.041409616 |
Resistant |
| ENSG00000224995.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.008082844 |
Resistant |
| ENSG00000225511.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.016349227 |
Resistant |
| ENSG00000225572.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.048036025 |
Resistant |
| ENSG00000225619.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.045796871 |
Resistant |
| ENSG00000225839.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.032510121 |
Resistant |
| ENSG00000225929.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.038496389 |
Resistant |
| ENSG00000226649.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.042845549 |
Resistant |
| ENSG00000226965.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.007333574 |
Resistant |
| ENSG00000227285.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.019458855 |
Resistant |
| ENSG00000227392.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.025059912 |
Resistant |
| ENSG00000227527.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.043060433 |
Resistant |
| ENSG00000228153.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.028043432 |
Resistant |
| ENSG00000228293.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.040657408 |
Resistant |
| ENSG00000228340.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.043682396 |
Resistant |
| ENSG00000228487.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.041689606 |
Resistant |
| ENSG00000229214.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.023256722 |
Resistant |
| ENSG00000229891.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.018895951 |
Resistant |
| ENSG00000230172.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.039532821 |
Resistant |
| ENSG00000230212.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.012686582 |
Resistant |
| ENSG00000231437.3 |
Gemcitabine |
Lung squamous cell carcinoma |
0.038727547 |
Resistant |
| ENSG00000231636.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.044533364 |
Resistant |
| ENSG00000231842.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.02665302 |
Resistant |
| ENSG00000231964.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.029217063 |
Resistant |
| ENSG00000233251.3 |
Gemcitabine |
Lung squamous cell carcinoma |
0.031226625 |
Resistant |
| ENSG00000233334.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.040354563 |
Resistant |
| ENSG00000233693.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.002532263 |
Resistant |
| ENSG00000234892.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.028754128 |
Resistant |
| ENSG00000234921.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.028154021 |
Resistant |
| ENSG00000235033.3 |
Gemcitabine |
Lung squamous cell carcinoma |
0.034583369 |
Resistant |
| ENSG00000235159.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.045680042 |
Resistant |
| ENSG00000235475.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.022831325 |
Resistant |
| ENSG00000235785.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.012040685 |
Resistant |
| ENSG00000236107.3 |
Gemcitabine |
Lung squamous cell carcinoma |
0.027273823 |
Resistant |
| ENSG00000236197.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.02364372 |
Resistant |
| ENSG00000236358.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.029060201 |
Resistant |
| ENSG00000236426.3 |
Gemcitabine |
Lung squamous cell carcinoma |
0.043072711 |
Resistant |
| ENSG00000236668.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.041108702 |
Resistant |
| ENSG00000236869.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.009533846 |
Resistant |
| ENSG00000237021.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.040729032 |
Resistant |
| ENSG00000237027.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.007829852 |
Resistant |
| ENSG00000237481.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.025853764 |
Resistant |
| ENSG00000237605.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.030046499 |
Resistant |
| ENSG00000237927.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.033306557 |
Resistant |
| ENSG00000237928.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.045000228 |
Resistant |
| ENSG00000239674.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.039144317 |
Resistant |
| ENSG00000240219.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.030834986 |
Resistant |
| ENSG00000242540.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.023037704 |
Resistant |
| ENSG00000242828.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.043616032 |
Resistant |
| ENSG00000243810.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.044837275 |
Resistant |
| ENSG00000244968.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.03274411 |
Resistant |
| ENSG00000246528.3 |
Gemcitabine |
Lung squamous cell carcinoma |
0.026941414 |
Resistant |
| ENSG00000248663.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.048022613 |
Resistant |
| ENSG00000248925.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.047901197 |
Resistant |
| ENSG00000249430.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.043080278 |
Resistant |
| ENSG00000249734.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.020472542 |
Resistant |
| ENSG00000250056.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.036019947 |
Resistant |
| ENSG00000250073.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.037999089 |
Resistant |
| ENSG00000250519.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.034870054 |
Resistant |
| ENSG00000251331.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.048917152 |
Resistant |
| ENSG00000251497.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.031757109 |
Resistant |
| ENSG00000253842.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.046291917 |
Resistant |
| ENSG00000253978.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.026712468 |
Resistant |
| ENSG00000254008.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.02836072 |
Resistant |
| ENSG00000254101.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.049175895 |
Resistant |
| ENSG00000254129.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.033603738 |
Resistant |
| ENSG00000254427.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.014345389 |
Resistant |
| ENSG00000254821.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.024595903 |
Resistant |
| ENSG00000255164.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.002277847 |
Resistant |
| ENSG00000255366.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.049539224 |
Resistant |
| ENSG00000255372.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.048944055 |
Resistant |
| ENSG00000255495.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.037916402 |
Resistant |
| ENSG00000255693.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.044990201 |
Resistant |
| ENSG00000256360.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.021207969 |
Resistant |
| ENSG00000256596.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.049808794 |
Resistant |
| ENSG00000257095.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.036923197 |
Resistant |
| ENSG00000257910.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.044611383 |
Resistant |
| ENSG00000259343.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.025480827 |
Resistant |
| ENSG00000259652.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.042714134 |
Resistant |
| ENSG00000259954.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.024731729 |
Resistant |
| ENSG00000259969.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.023847025 |
Resistant |
| ENSG00000260148.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.039764952 |
Resistant |
| ENSG00000260173.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.030361199 |
Resistant |
| ENSG00000260193.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.011934601 |
Resistant |
| ENSG00000260331.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.006643801 |
Resistant |
| ENSG00000260398.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.027799577 |
Resistant |
| ENSG00000260400.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.047299711 |
Resistant |
| ENSG00000260583.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.00893066 |
Resistant |
| ENSG00000260750.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.020910542 |
Resistant |
| ENSG00000260787.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.03170713 |
Resistant |
| ENSG00000260931.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.044531221 |
Resistant |
| ENSG00000261170.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.045183302 |
Resistant |
| ENSG00000261185.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.042244787 |
Resistant |
| ENSG00000261462.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.03659284 |
Resistant |
| ENSG00000262810.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.005599848 |
Resistant |
| ENSG00000262881.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.003296281 |
Resistant |
| ENSG00000262921.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.014335155 |
Resistant |
| ENSG00000263015.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.013546395 |
Resistant |
| ENSG00000263717.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.045986678 |
Resistant |
| ENSG00000263924.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.0419531 |
Resistant |
| ENSG00000263938.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.041549831 |
Resistant |
| ENSG00000264272.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.042198813 |
Resistant |
| ENSG00000264365.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.012793862 |
Resistant |
| ENSG00000264589.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.023807039 |
Resistant |
| ENSG00000264924.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.005302775 |
Resistant |
| ENSG00000265094.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.046494138 |
Resistant |
| ENSG00000265204.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.023659459 |
Resistant |
| ENSG00000266290.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.009095302 |
Resistant |
| ENSG00000266441.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.044945212 |
Resistant |
| ENSG00000266911.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.019843272 |
Resistant |
| ENSG00000267095.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.011787793 |
Resistant |
| ENSG00000267202.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.038497957 |
Resistant |
| ENSG00000267298.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.015571234 |
Resistant |
| ENSG00000267480.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.0096449 |
Resistant |
| ENSG00000267499.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.042383553 |
Resistant |
| ENSG00000267677.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.009590468 |
Resistant |
| ENSG00000267701.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.004181502 |
Resistant |
| ENSG00000268536.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.024131966 |
Resistant |
| ENSG00000268543.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.016127725 |
Resistant |
| ENSG00000269473.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.022800167 |
Resistant |
| ENSG00000269944.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.017788951 |
Resistant |
| ENSG00000270154.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.018969759 |
Resistant |
| ENSG00000270189.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.029806408 |
Resistant |
| ENSG00000271119.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.008285039 |
Resistant |
| ENSG00000271738.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.047006105 |
Resistant |
| ENSG00000271782.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.003999571 |
Resistant |
| ENSG00000271803.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.023867377 |
Resistant |
| ENSG00000271916.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.049455886 |
Resistant |
| ENSG00000271981.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.016918433 |
Resistant |
| ENSG00000272002.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.012658217 |
Resistant |
| ENSG00000272077.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.023946688 |
Resistant |
| ENSG00000272180.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.012804494 |
Resistant |
| ENSG00000272372.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.048508234 |
Resistant |
| ENSG00000272379.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.041817103 |
Resistant |
| ENSG00000272446.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.037937444 |
Resistant |
| ENSG00000272452.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.02757496 |
Resistant |
| ENSG00000272516.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.00939713 |
Resistant |
| ENSG00000272562.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.044110402 |
Resistant |
| ENSG00000272717.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.029199615 |
Resistant |
| ENSG00000273175.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.024366553 |
Resistant |
| ENSG00000273472.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.013151239 |
Resistant |
| ENSG00000273474.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.034321083 |
Resistant |
| ENSG00000224216.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.046229154 |
Resistant |
| ENSG00000230487.3 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.046512839 |
Resistant |
| ENSG00000233303.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.027597573 |
Resistant |
| ENSG00000235726.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.039453365 |
Resistant |
| ENSG00000237489.2 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.040891797 |
Resistant |
| ENSG00000237520.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.01339468 |
Resistant |
| ENSG00000243849.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.018919582 |
Resistant |
| ENSG00000246790.2 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.034950277 |
Resistant |
| ENSG00000254099.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.023870328 |
Resistant |
| ENSG00000255557.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.04896808 |
Resistant |
| ENSG00000258088.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.00654028 |
Resistant |
| ENSG00000260657.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.032526542 |
Resistant |
| ENSG00000261126.3 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.025826755 |
Resistant |
| ENSG00000262094.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.029163092 |
Resistant |
| ENSG00000262185.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.012703848 |
Resistant |
| ENSG00000264964.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.04019966 |
Resistant |
| ENSG00000266717.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.014227156 |
Resistant |
| ENSG00000177822.3 |
Gemcitabine |
Sarcoma |
0.00493271 |
Resistant |
| ENSG00000203307.2 |
Gemcitabine |
Sarcoma |
0.038543941 |
Resistant |
| ENSG00000214407.3 |
Gemcitabine |
Sarcoma |
0.004896995 |
Resistant |
| ENSG00000214770.2 |
Gemcitabine |
Sarcoma |
0.001963583 |
Resistant |
| ENSG00000223842.1 |
Gemcitabine |
Sarcoma |
0.009429421 |
Resistant |
| ENSG00000224216.1 |
Gemcitabine |
Sarcoma |
0.005291364 |
Resistant |
| ENSG00000224549.1 |
Gemcitabine |
Sarcoma |
0.01949424 |
Resistant |
| ENSG00000224871.1 |
Gemcitabine |
Sarcoma |
0.014153106 |
Resistant |
| ENSG00000224950.1 |
Gemcitabine |
Sarcoma |
0.002101325 |
Resistant |
| ENSG00000225791.2 |
Gemcitabine |
Sarcoma |
0.009830663 |
Resistant |
| ENSG00000227082.1 |
Gemcitabine |
Sarcoma |
0.044966815 |
Resistant |
| ENSG00000227477.1 |
Gemcitabine |
Sarcoma |
0.004971742 |
Resistant |
| ENSG00000227482.1 |
Gemcitabine |
Sarcoma |
0.004886718 |
Resistant |
| ENSG00000227517.2 |
Gemcitabine |
Sarcoma |
0.001328374 |
Resistant |
| ENSG00000227627.1 |
Gemcitabine |
Sarcoma |
0.022256284 |
Resistant |
| ENSG00000227733.4 |
Gemcitabine |
Sarcoma |
0.029227412 |
Resistant |
| ENSG00000228412.2 |
Gemcitabine |
Sarcoma |
0.000734136 |
Resistant |
| ENSG00000228624.3 |
Gemcitabine |
Sarcoma |
0.01547666 |
Resistant |
| ENSG00000228775.3 |
Gemcitabine |
Sarcoma |
0.01157051 |
Resistant |
| ENSG00000229404.1 |
Gemcitabine |
Sarcoma |
0.023429528 |
Resistant |
| ENSG00000229841.1 |
Gemcitabine |
Sarcoma |
0.043664401 |
Resistant |
| ENSG00000229867.1 |
Gemcitabine |
Sarcoma |
0.005565398 |
Resistant |
| ENSG00000230914.2 |
Gemcitabine |
Sarcoma |
0.018457904 |
Resistant |
| ENSG00000230939.1 |
Gemcitabine |
Sarcoma |
0.001772167 |
Resistant |
| ENSG00000231290.1 |
Gemcitabine |
Sarcoma |
0.041610775 |
Resistant |
| ENSG00000231595.1 |
Gemcitabine |
Sarcoma |
0.04028858 |
Resistant |
| ENSG00000231877.1 |
Gemcitabine |
Sarcoma |
0.034402588 |
Resistant |
| ENSG00000232117.1 |
Gemcitabine |
Sarcoma |
0.01722906 |
Resistant |
| ENSG00000232545.1 |
Gemcitabine |
Sarcoma |
0.036588476 |
Resistant |
| ENSG00000235246.1 |
Gemcitabine |
Sarcoma |
0.02279689 |
Resistant |
| ENSG00000235806.1 |
Gemcitabine |
Sarcoma |
0.021948825 |
Resistant |
| ENSG00000236091.1 |
Gemcitabine |
Sarcoma |
0.015716566 |
Resistant |
| ENSG00000236581.4 |
Gemcitabine |
Sarcoma |
0.014611035 |
Resistant |
| ENSG00000236658.1 |
Gemcitabine |
Sarcoma |
0.014135513 |
Resistant |
| ENSG00000237596.2 |
Gemcitabine |
Sarcoma |
0.02792086 |
Resistant |
| ENSG00000238273.3 |
Gemcitabine |
Sarcoma |
0.016697097 |
Resistant |
| ENSG00000240766.1 |
Gemcitabine |
Sarcoma |
0.021542214 |
Resistant |
| ENSG00000241280.1 |
Gemcitabine |
Sarcoma |
0.003681633 |
Resistant |
| ENSG00000242797.2 |
Gemcitabine |
Sarcoma |
0.039577106 |
Resistant |
| ENSG00000243797.2 |
Gemcitabine |
Sarcoma |
0.043544479 |
Resistant |
| ENSG00000243849.1 |
Gemcitabine |
Sarcoma |
0.009236756 |
Resistant |
| ENSG00000245060.2 |
Gemcitabine |
Sarcoma |
0.013462905 |
Resistant |
| ENSG00000245149.3 |
Gemcitabine |
Sarcoma |
0.025096861 |
Resistant |
| ENSG00000248161.1 |
Gemcitabine |
Sarcoma |
0.00718836 |
Resistant |
| ENSG00000248187.1 |
Gemcitabine |
Sarcoma |
0.02678925 |
Resistant |
| ENSG00000248846.2 |
Gemcitabine |
Sarcoma |
0.018605428 |
Resistant |
| ENSG00000249216.1 |
Gemcitabine |
Sarcoma |
0.008223505 |
Resistant |
| ENSG00000249395.2 |
Gemcitabine |
Sarcoma |
0.037611999 |
Resistant |
| ENSG00000249610.1 |
Gemcitabine |
Sarcoma |
0.038940209 |
Resistant |
| ENSG00000250155.1 |
Gemcitabine |
Sarcoma |
0.046888532 |
Resistant |
| ENSG00000250548.2 |
Gemcitabine |
Sarcoma |
0.012092652 |
Resistant |
| ENSG00000250822.1 |
Gemcitabine |
Sarcoma |
0.021527502 |
Resistant |
| ENSG00000250910.3 |
Gemcitabine |
Sarcoma |
0.004319791 |
Resistant |
| ENSG00000251003.3 |
Gemcitabine |
Sarcoma |
0.037030976 |
Resistant |
| ENSG00000251350.1 |
Gemcitabine |
Sarcoma |
0.00000268 |
Resistant |
| ENSG00000253106.1 |
Gemcitabine |
Sarcoma |
0.044389399 |
Resistant |
| ENSG00000253222.1 |
Gemcitabine |
Sarcoma |
0.044746334 |
Resistant |
| ENSG00000253582.1 |
Gemcitabine |
Sarcoma |
0.025288759 |
Resistant |
| ENSG00000253796.1 |
Gemcitabine |
Sarcoma |
0.000867678 |
Resistant |
| ENSG00000253825.1 |
Gemcitabine |
Sarcoma |
0.039825115 |
Resistant |
| ENSG00000254231.1 |
Gemcitabine |
Sarcoma |
0.019365667 |
Resistant |
| ENSG00000254275.2 |
Gemcitabine |
Sarcoma |
0.025069709 |
Resistant |
| ENSG00000255129.1 |
Gemcitabine |
Sarcoma |
0.006946964 |
Resistant |
| ENSG00000256001.1 |
Gemcitabine |
Sarcoma |
0.021062911 |
Resistant |
| ENSG00000256124.1 |
Gemcitabine |
Sarcoma |
0.018831315 |
Resistant |
| ENSG00000256615.1 |
Gemcitabine |
Sarcoma |
0.009311438 |
Resistant |
| ENSG00000257557.1 |
Gemcitabine |
Sarcoma |
0.007541045 |
Resistant |
| ENSG00000258410.1 |
Gemcitabine |
Sarcoma |
0.025307837 |
Resistant |
| ENSG00000258919.1 |
Gemcitabine |
Sarcoma |
0.008419294 |
Resistant |
| ENSG00000258942.1 |
Gemcitabine |
Sarcoma |
0.03705655 |
Resistant |
| ENSG00000259126.1 |
Gemcitabine |
Sarcoma |
0.009983294 |
Resistant |
| ENSG00000259172.1 |
Gemcitabine |
Sarcoma |
0.020222631 |
Resistant |
| ENSG00000259212.1 |
Gemcitabine |
Sarcoma |
0.020021607 |
Resistant |
| ENSG00000259319.1 |
Gemcitabine |
Sarcoma |
0.017189907 |
Resistant |
| ENSG00000259349.1 |
Gemcitabine |
Sarcoma |
0.012928063 |
Resistant |
| ENSG00000259523.1 |
Gemcitabine |
Sarcoma |
0.035536937 |
Resistant |
| ENSG00000259631.1 |
Gemcitabine |
Sarcoma |
0.029587305 |
Resistant |
| ENSG00000259774.1 |
Gemcitabine |
Sarcoma |
0.035121265 |
Resistant |
| ENSG00000260588.1 |
Gemcitabine |
Sarcoma |
0.018911515 |
Resistant |
| ENSG00000260971.3 |
Gemcitabine |
Sarcoma |
0.023763276 |
Resistant |
| ENSG00000261770.1 |
Gemcitabine |
Sarcoma |
0.042458909 |
Resistant |
| ENSG00000263674.1 |
Gemcitabine |
Sarcoma |
0.016187522 |
Resistant |
| ENSG00000265458.1 |
Gemcitabine |
Sarcoma |
0.03938186 |
Resistant |
| ENSG00000265766.1 |
Gemcitabine |
Sarcoma |
0.045889619 |
Resistant |
| ENSG00000267058.1 |
Gemcitabine |
Sarcoma |
0.012771306 |
Resistant |
| ENSG00000267067.1 |
Gemcitabine |
Sarcoma |
0.018384056 |
Resistant |
| ENSG00000267342.1 |
Gemcitabine |
Sarcoma |
0.034081106 |
Resistant |
| ENSG00000267470.1 |
Gemcitabine |
Sarcoma |
0.002573788 |
Resistant |
| ENSG00000267605.1 |
Gemcitabine |
Sarcoma |
0.044936196 |
Resistant |
| ENSG00000269938.1 |
Gemcitabine |
Sarcoma |
0.030160001 |
Resistant |
| ENSG00000269951.1 |
Gemcitabine |
Sarcoma |
0.049556428 |
Resistant |
| ENSG00000269997.1 |
Gemcitabine |
Sarcoma |
0.032620904 |
Resistant |
| ENSG00000270720.1 |
Gemcitabine |
Sarcoma |
0.024244506 |
Resistant |
| ENSG00000271821.1 |
Gemcitabine |
Sarcoma |
0.038987755 |
Resistant |
| ENSG00000272070.1 |
Gemcitabine |
Sarcoma |
0.026147063 |
Resistant |
| ENSG00000272425.1 |
Gemcitabine |
Sarcoma |
0.040149132 |
Resistant |
| ENSG00000272544.1 |
Gemcitabine |
Sarcoma |
0.029281704 |
Resistant |
| ENSG00000272564.1 |
Gemcitabine |
Sarcoma |
0.045166773 |
Resistant |
| ENSG00000272719.1 |
Gemcitabine |
Sarcoma |
0.038077462 |
Resistant |
| ENSG00000272966.1 |
Gemcitabine |
Sarcoma |
0.030208743 |
Resistant |
| ENSG00000273447.1 |
Gemcitabine |
Sarcoma |
0.025542924 |
Resistant |
| ENSG00000170161.6 |
Gemcitabine |
Skin cutaneous melanoma |
0.028763054 |
Resistant |
| ENSG00000178947.8 |
Gemcitabine |
Skin cutaneous melanoma |
0.019366581 |
Resistant |
| ENSG00000182165.13 |
Gemcitabine |
Skin cutaneous melanoma |
0.025836966 |
Resistant |
| ENSG00000203506.3 |
Gemcitabine |
Skin cutaneous melanoma |
0.024708954 |
Resistant |
| ENSG00000214650.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.026639426 |
Resistant |
| ENSG00000223839.3 |
Gemcitabine |
Skin cutaneous melanoma |
0.010483612 |
Resistant |
| ENSG00000225353.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.021847147 |
Resistant |
| ENSG00000225511.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.00242363 |
Resistant |
| ENSG00000226380.3 |
Gemcitabine |
Skin cutaneous melanoma |
0.02413753 |
Resistant |
| ENSG00000226812.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.010149801 |
Resistant |
| ENSG00000227719.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.039747452 |
Resistant |
| ENSG00000227888.3 |
Gemcitabine |
Skin cutaneous melanoma |
0.048232236 |
Resistant |
| ENSG00000228526.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.005492898 |
Resistant |
| ENSG00000230433.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.023117119 |
Resistant |
| ENSG00000230658.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.006766163 |
Resistant |
| ENSG00000231367.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.033721312 |
Resistant |
| ENSG00000231422.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.000752617 |
Resistant |
| ENSG00000231527.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.047816568 |
Resistant |
| ENSG00000232986.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.042660006 |
Resistant |
| ENSG00000233178.3 |
Gemcitabine |
Skin cutaneous melanoma |
0.032911453 |
Resistant |
| ENSG00000233244.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.017132743 |
Resistant |
| ENSG00000233642.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.019090201 |
Resistant |
| ENSG00000234535.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.034390128 |
Resistant |
| ENSG00000234546.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.009164016 |
Resistant |
| ENSG00000236449.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.010450448 |
Resistant |
| ENSG00000237298.4 |
Gemcitabine |
Skin cutaneous melanoma |
0.011590413 |
Resistant |
| ENSG00000239774.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.026098527 |
Resistant |
| ENSG00000244198.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.033513108 |
Resistant |
| ENSG00000244479.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.016448631 |
Resistant |
| ENSG00000245532.4 |
Gemcitabine |
Skin cutaneous melanoma |
0.025379012 |
Resistant |
| ENSG00000245534.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.038599765 |
Resistant |
| ENSG00000245552.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.007314701 |
Resistant |
| ENSG00000249307.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.027094135 |
Resistant |
| ENSG00000250057.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.036311208 |
Resistant |
| ENSG00000250286.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.003827597 |
Resistant |
| ENSG00000250948.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.018645504 |
Resistant |
| ENSG00000251141.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.03701531 |
Resistant |
| ENSG00000251330.3 |
Gemcitabine |
Skin cutaneous melanoma |
0.030854656 |
Resistant |
| ENSG00000253174.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.005544122 |
Resistant |
| ENSG00000253875.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.024575867 |
Resistant |
| ENSG00000254739.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.023017526 |
Resistant |
| ENSG00000254900.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.025095474 |
Resistant |
| ENSG00000254987.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.04979544 |
Resistant |
| ENSG00000256325.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.037347448 |
Resistant |
| ENSG00000256894.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.048126388 |
Resistant |
| ENSG00000257135.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.026844463 |
Resistant |
| ENSG00000260132.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.030627789 |
Resistant |
| ENSG00000261033.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.01446913 |
Resistant |
| ENSG00000261584.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.04006382 |
Resistant |
| ENSG00000265478.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.005702738 |
Resistant |
| ENSG00000267006.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.041592355 |
Resistant |
| ENSG00000267758.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.018619094 |
Resistant |
| ENSG00000268095.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.004063603 |
Resistant |
| ENSG00000268670.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.037986034 |
Resistant |
| ENSG00000269553.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.018019882 |
Resistant |
| ENSG00000272108.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.035668237 |
Resistant |
| ENSG00000272970.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.043143241 |
Resistant |
| ENSG00000273084.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.015153948 |
Resistant |
| ENSG00000273451.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.049405292 |
Resistant |
| ENSG00000177822.3 |
Gemcitabine |
Thyroid carcinoma |
0.049325992 |
Resistant |
| ENSG00000203327.2 |
Gemcitabine |
Thyroid carcinoma |
0.003709026 |
Resistant |
| ENSG00000223685.1 |
Gemcitabine |
Thyroid carcinoma |
0.020029692 |
Resistant |
| ENSG00000223695.1 |
Gemcitabine |
Thyroid carcinoma |
0.041661573 |
Resistant |
| ENSG00000227844.1 |
Gemcitabine |
Thyroid carcinoma |
0.049775512 |
Resistant |
| ENSG00000228340.1 |
Gemcitabine |
Thyroid carcinoma |
0.048436083 |
Resistant |
| ENSG00000232031.1 |
Gemcitabine |
Thyroid carcinoma |
0.024303456 |
Resistant |
| ENSG00000232732.5 |
Gemcitabine |
Thyroid carcinoma |
0.025008235 |
Resistant |
| ENSG00000234019.1 |
Gemcitabine |
Thyroid carcinoma |
0.00627053 |
Resistant |
| ENSG00000234428.2 |
Gemcitabine |
Thyroid carcinoma |
0.044024175 |
Resistant |
| ENSG00000236064.1 |
Gemcitabine |
Thyroid carcinoma |
0.006837042 |
Resistant |
| ENSG00000236404.4 |
Gemcitabine |
Thyroid carcinoma |
0.019494736 |
Resistant |
| ENSG00000251574.2 |
Gemcitabine |
Thyroid carcinoma |
0.017403189 |
Resistant |
| ENSG00000253399.1 |
Gemcitabine |
Thyroid carcinoma |
0.032423842 |
Resistant |
| ENSG00000253420.1 |
Gemcitabine |
Thyroid carcinoma |
0.0196444 |
Resistant |
| ENSG00000255052.3 |
Gemcitabine |
Thyroid carcinoma |
0.010206567 |
Resistant |
| ENSG00000256325.1 |
Gemcitabine |
Thyroid carcinoma |
0.029870344 |
Resistant |
| ENSG00000257568.1 |
Gemcitabine |
Thyroid carcinoma |
0.02339004 |
Resistant |
| ENSG00000258904.1 |
Gemcitabine |
Thyroid carcinoma |
0.04577678 |
Resistant |
| ENSG00000259792.1 |
Gemcitabine |
Thyroid carcinoma |
0.011621106 |
Resistant |
| ENSG00000259804.1 |
Gemcitabine |
Thyroid carcinoma |
0.033617814 |
Resistant |
| ENSG00000259865.1 |
Gemcitabine |
Thyroid carcinoma |
0.021262223 |
Resistant |
| ENSG00000260706.1 |
Gemcitabine |
Thyroid carcinoma |
0.038256632 |
Resistant |
| ENSG00000263680.2 |
Gemcitabine |
Thyroid carcinoma |
0.012718529 |
Resistant |
| ENSG00000263924.1 |
Gemcitabine |
Thyroid carcinoma |
0.016942013 |
Resistant |
| ENSG00000270019.1 |
Gemcitabine |
Thyroid carcinoma |
0.031631322 |
Resistant |
| ENSG00000272583.1 |
Gemcitabine |
Thyroid carcinoma |
0.042627882 |
Resistant |
| ENSG00000272977.1 |
Gemcitabine |
Thyroid carcinoma |
0.035005489 |
Resistant |
| ENSG00000223759.2 |
Gemcitabine |
Bladder urothelial carcinoma |
0.019470041 |
Sensitive |
| ENSG00000224804.4 |
Gemcitabine |
Bladder urothelial carcinoma |
0.013663463 |
Sensitive |
| ENSG00000224846.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.026533768 |
Sensitive |
| ENSG00000225969.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.02634905 |
Sensitive |
| ENSG00000226067.2 |
Gemcitabine |
Bladder urothelial carcinoma |
0.014711722 |
Sensitive |
| ENSG00000227017.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.001365979 |
Sensitive |
| ENSG00000228288.2 |
Gemcitabine |
Bladder urothelial carcinoma |
0.047632111 |
Sensitive |
| ENSG00000233483.2 |
Gemcitabine |
Bladder urothelial carcinoma |
0.010540971 |
Sensitive |
| ENSG00000233757.2 |
Gemcitabine |
Bladder urothelial carcinoma |
0.04885728 |
Sensitive |
| ENSG00000235999.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.038407439 |
Sensitive |
| ENSG00000243926.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.044528598 |
Sensitive |
| ENSG00000245248.3 |
Gemcitabine |
Bladder urothelial carcinoma |
0.017428094 |
Sensitive |
| ENSG00000259251.2 |
Gemcitabine |
Bladder urothelial carcinoma |
0.026854588 |
Sensitive |
| ENSG00000260173.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.012566579 |
Sensitive |
| ENSG00000266120.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.044754638 |
Sensitive |
| ENSG00000271888.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.038210907 |
Sensitive |
| ENSG00000271912.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.048892541 |
Sensitive |
| ENSG00000272053.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.038377556 |
Sensitive |
| ENSG00000272209.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.041416617 |
Sensitive |
| ENSG00000273073.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.031000974 |
Sensitive |
| ENSG00000273265.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.027062218 |
Sensitive |
| ENSG00000273367.1 |
Gemcitabine |
Bladder urothelial carcinoma |
0.013755909 |
Sensitive |
| ENSG00000182057.4 |
Gemcitabine |
Breast invasive carcinoma |
0.043643539 |
Sensitive |
| ENSG00000230423.1 |
Gemcitabine |
Breast invasive carcinoma |
0.030941802 |
Sensitive |
| ENSG00000233862.1 |
Gemcitabine |
Breast invasive carcinoma |
0.03483634 |
Sensitive |
| ENSG00000236438.2 |
Gemcitabine |
Breast invasive carcinoma |
0.003008763 |
Sensitive |
| ENSG00000240211.1 |
Gemcitabine |
Breast invasive carcinoma |
0.045407748 |
Sensitive |
| ENSG00000250073.2 |
Gemcitabine |
Breast invasive carcinoma |
0.0474212 |
Sensitive |
| ENSG00000253701.1 |
Gemcitabine |
Breast invasive carcinoma |
0.04347028 |
Sensitive |
| ENSG00000259439.1 |
Gemcitabine |
Breast invasive carcinoma |
0.029536716 |
Sensitive |
| ENSG00000260757.1 |
Gemcitabine |
Breast invasive carcinoma |
0.04596913 |
Sensitive |
| ENSG00000261441.1 |
Gemcitabine |
Breast invasive carcinoma |
0.011810915 |
Sensitive |
| ENSG00000261572.1 |
Gemcitabine |
Breast invasive carcinoma |
0.035325568 |
Sensitive |
| ENSG00000272861.1 |
Gemcitabine |
Breast invasive carcinoma |
0.049027117 |
Sensitive |
| ENSG00000185203.7 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.008194669 |
Sensitive |
| ENSG00000203808.6 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035373332 |
Sensitive |
| ENSG00000224761.2 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040943829 |
Sensitive |
| ENSG00000227014.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042430665 |
Sensitive |
| ENSG00000229702.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.034860858 |
Sensitive |
| ENSG00000229999.2 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031896688 |
Sensitive |
| ENSG00000230061.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045992661 |
Sensitive |
| ENSG00000230074.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.003376966 |
Sensitive |
| ENSG00000231028.4 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.020338506 |
Sensitive |
| ENSG00000235499.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.049902075 |
Sensitive |
| ENSG00000245685.2 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038537108 |
Sensitive |
| ENSG00000247516.3 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041941896 |
Sensitive |
| ENSG00000250007.2 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013265456 |
Sensitive |
| ENSG00000251143.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039921413 |
Sensitive |
| ENSG00000254248.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03935807 |
Sensitive |
| ENSG00000254510.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.026879136 |
Sensitive |
| ENSG00000260186.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.043353724 |
Sensitive |
| ENSG00000261766.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.036214131 |
Sensitive |
| ENSG00000263860.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.036368925 |
Sensitive |
| ENSG00000264469.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.009780299 |
Sensitive |
| ENSG00000265688.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.033293856 |
Sensitive |
| ENSG00000267040.2 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.025709101 |
Sensitive |
| ENSG00000267268.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.026434047 |
Sensitive |
| ENSG00000267651.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.028163225 |
Sensitive |
| ENSG00000267787.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.019323566 |
Sensitive |
| ENSG00000267919.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035759189 |
Sensitive |
| ENSG00000270141.2 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013708003 |
Sensitive |
| ENSG00000270237.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031887933 |
Sensitive |
| ENSG00000271265.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.014357321 |
Sensitive |
| ENSG00000272368.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042103183 |
Sensitive |
| ENSG00000272452.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.046152855 |
Sensitive |
| ENSG00000272764.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017961911 |
Sensitive |
| ENSG00000272914.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031779093 |
Sensitive |
| ENSG00000273307.1 |
Gemcitabine |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.030211751 |
Sensitive |
| ENSG00000204528.3 |
Gemcitabine |
Colon adenocarcinoma |
0.038288631 |
Sensitive |
| ENSG00000223598.1 |
Gemcitabine |
Colon adenocarcinoma |
0.049580419 |
Sensitive |
| ENSG00000223660.1 |
Gemcitabine |
Colon adenocarcinoma |
0.009708404 |
Sensitive |
| ENSG00000224992.1 |
Gemcitabine |
Colon adenocarcinoma |
0.020346348 |
Sensitive |
| ENSG00000225092.2 |
Gemcitabine |
Colon adenocarcinoma |
0.014976963 |
Sensitive |
| ENSG00000225767.1 |
Gemcitabine |
Colon adenocarcinoma |
0.017744191 |
Sensitive |
| ENSG00000226792.2 |
Gemcitabine |
Colon adenocarcinoma |
0.016255225 |
Sensitive |
| ENSG00000227676.2 |
Gemcitabine |
Colon adenocarcinoma |
0.030942754 |
Sensitive |
| ENSG00000228437.1 |
Gemcitabine |
Colon adenocarcinoma |
0.023998767 |
Sensitive |
| ENSG00000230612.1 |
Gemcitabine |
Colon adenocarcinoma |
0.01811872 |
Sensitive |
| ENSG00000231226.1 |
Gemcitabine |
Colon adenocarcinoma |
0.041572728 |
Sensitive |
| ENSG00000232116.2 |
Gemcitabine |
Colon adenocarcinoma |
0.039488164 |
Sensitive |
| ENSG00000232628.1 |
Gemcitabine |
Colon adenocarcinoma |
0.04840002 |
Sensitive |
| ENSG00000233144.1 |
Gemcitabine |
Colon adenocarcinoma |
0.022259196 |
Sensitive |
| ENSG00000234943.2 |
Gemcitabine |
Colon adenocarcinoma |
0.018940692 |
Sensitive |
| ENSG00000235419.1 |
Gemcitabine |
Colon adenocarcinoma |
0.049396605 |
Sensitive |
| ENSG00000236066.1 |
Gemcitabine |
Colon adenocarcinoma |
0.020772049 |
Sensitive |
| ENSG00000237328.1 |
Gemcitabine |
Colon adenocarcinoma |
0.021386681 |
Sensitive |
| ENSG00000237336.1 |
Gemcitabine |
Colon adenocarcinoma |
0.0137054 |
Sensitive |
| ENSG00000243849.1 |
Gemcitabine |
Colon adenocarcinoma |
0.003231708 |
Sensitive |
| ENSG00000249550.2 |
Gemcitabine |
Colon adenocarcinoma |
0.034182173 |
Sensitive |
| ENSG00000249717.1 |
Gemcitabine |
Colon adenocarcinoma |
0.018502956 |
Sensitive |
| ENSG00000250614.1 |
Gemcitabine |
Colon adenocarcinoma |
0.03176995 |
Sensitive |
| ENSG00000257279.1 |
Gemcitabine |
Colon adenocarcinoma |
0.046923254 |
Sensitive |
| ENSG00000258604.1 |
Gemcitabine |
Colon adenocarcinoma |
0.002003232 |
Sensitive |
| ENSG00000260558.1 |
Gemcitabine |
Colon adenocarcinoma |
0.039890724 |
Sensitive |
| ENSG00000260592.1 |
Gemcitabine |
Colon adenocarcinoma |
0.018471277 |
Sensitive |
| ENSG00000263657.1 |
Gemcitabine |
Colon adenocarcinoma |
0.005953731 |
Sensitive |
| ENSG00000266397.1 |
Gemcitabine |
Colon adenocarcinoma |
0.009606276 |
Sensitive |
| ENSG00000267003.1 |
Gemcitabine |
Colon adenocarcinoma |
0.046921042 |
Sensitive |
| ENSG00000267026.1 |
Gemcitabine |
Colon adenocarcinoma |
0.015288532 |
Sensitive |
| ENSG00000267696.2 |
Gemcitabine |
Colon adenocarcinoma |
0.033742963 |
Sensitive |
| ENSG00000271127.1 |
Gemcitabine |
Colon adenocarcinoma |
0.046443863 |
Sensitive |
| ENSG00000271778.1 |
Gemcitabine |
Colon adenocarcinoma |
0.037273788 |
Sensitive |
| ENSG00000272128.1 |
Gemcitabine |
Colon adenocarcinoma |
0.041140323 |
Sensitive |
| ENSG00000272219.1 |
Gemcitabine |
Colon adenocarcinoma |
0.027908411 |
Sensitive |
| ENSG00000272872.1 |
Gemcitabine |
Colon adenocarcinoma |
0.012505178 |
Sensitive |
| ENSG00000273073.1 |
Gemcitabine |
Colon adenocarcinoma |
0.025497424 |
Sensitive |
| ENSG00000174171.4 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015415877 |
Sensitive |
| ENSG00000179406.6 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027695075 |
Sensitive |
| ENSG00000186594.8 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041328011 |
Sensitive |
| ENSG00000203496.4 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03268372 |
Sensitive |
| ENSG00000204054.7 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016817762 |
Sensitive |
| ENSG00000204815.4 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044187078 |
Sensitive |
| ENSG00000205885.3 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005550018 |
Sensitive |
| ENSG00000212694.4 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005316975 |
Sensitive |
| ENSG00000213863.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023555418 |
Sensitive |
| ENSG00000213981.4 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028055088 |
Sensitive |
| ENSG00000215256.3 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020560254 |
Sensitive |
| ENSG00000215447.3 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000224418 |
Sensitive |
| ENSG00000223387.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049904291 |
Sensitive |
| ENSG00000223768.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001333288 |
Sensitive |
| ENSG00000224216.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032300757 |
Sensitive |
| ENSG00000224292.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047360019 |
Sensitive |
| ENSG00000224481.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015237848 |
Sensitive |
| ENSG00000224533.3 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002361053 |
Sensitive |
| ENSG00000224843.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03462382 |
Sensitive |
| ENSG00000225353.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036924838 |
Sensitive |
| ENSG00000225442.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021760129 |
Sensitive |
| ENSG00000225667.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001440124 |
Sensitive |
| ENSG00000226833.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010398962 |
Sensitive |
| ENSG00000226862.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025476748 |
Sensitive |
| ENSG00000227512.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02172682 |
Sensitive |
| ENSG00000227946.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004409113 |
Sensitive |
| ENSG00000228022.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008123104 |
Sensitive |
| ENSG00000228028.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044435726 |
Sensitive |
| ENSG00000228043.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017639659 |
Sensitive |
| ENSG00000228323.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041966857 |
Sensitive |
| ENSG00000228486.5 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035506139 |
Sensitive |
| ENSG00000228540.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036743531 |
Sensitive |
| ENSG00000228775.3 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013282357 |
Sensitive |
| ENSG00000228779.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044139983 |
Sensitive |
| ENSG00000228786.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038539226 |
Sensitive |
| ENSG00000228886.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017461473 |
Sensitive |
| ENSG00000229036.3 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030803371 |
Sensitive |
| ENSG00000229666.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020089962 |
Sensitive |
| ENSG00000229867.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011629234 |
Sensitive |
| ENSG00000229931.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00495316 |
Sensitive |
| ENSG00000230021.3 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024435002 |
Sensitive |
| ENSG00000230423.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035549405 |
Sensitive |
| ENSG00000230454.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025757567 |
Sensitive |
| ENSG00000230736.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0283712 |
Sensitive |
| ENSG00000230912.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039886691 |
Sensitive |
| ENSG00000231064.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024316381 |
Sensitive |
| ENSG00000231249.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027376636 |
Sensitive |
| ENSG00000231290.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007664797 |
Sensitive |
| ENSG00000231481.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013138432 |
Sensitive |
| ENSG00000231512.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002248194 |
Sensitive |
| ENSG00000231527.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014097274 |
Sensitive |
| ENSG00000231711.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024982302 |
Sensitive |
| ENSG00000232324.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003832239 |
Sensitive |
| ENSG00000232352.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026865221 |
Sensitive |
| ENSG00000232445.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048747783 |
Sensitive |
| ENSG00000232807.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049087103 |
Sensitive |
| ENSG00000232811.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043252191 |
Sensitive |
| ENSG00000233030.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030247134 |
Sensitive |
| ENSG00000233080.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030571111 |
Sensitive |
| ENSG00000233154.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014501429 |
Sensitive |
| ENSG00000233621.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027739932 |
Sensitive |
| ENSG00000234232.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030418742 |
Sensitive |
| ENSG00000234571.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001100712 |
Sensitive |
| ENSG00000235779.3 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029370152 |
Sensitive |
| ENSG00000235872.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037381093 |
Sensitive |
| ENSG00000235927.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039143453 |
Sensitive |
| ENSG00000236434.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033436654 |
Sensitive |
| ENSG00000236601.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038104287 |
Sensitive |
| ENSG00000237595.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0000187 |
Sensitive |
| ENSG00000237781.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032477833 |
Sensitive |
| ENSG00000238018.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047432161 |
Sensitive |
| ENSG00000241954.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01220253 |
Sensitive |
| ENSG00000242375.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023447075 |
Sensitive |
| ENSG00000248932.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020977665 |
Sensitive |
| ENSG00000249359.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032868598 |
Sensitive |
| ENSG00000249572.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003461409 |
Sensitive |
| ENSG00000249700.4 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022537824 |
Sensitive |
| ENSG00000249786.3 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047344917 |
Sensitive |
| ENSG00000250302.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009669799 |
Sensitive |
| ENSG00000250765.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002107646 |
Sensitive |
| ENSG00000251562.3 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01597383 |
Sensitive |
| ENSG00000255455.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022281113 |
Sensitive |
| ENSG00000255741.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00566112 |
Sensitive |
| ENSG00000255992.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04876268 |
Sensitive |
| ENSG00000256967.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000558673 |
Sensitive |
| ENSG00000257298.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043778914 |
Sensitive |
| ENSG00000257354.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042760828 |
Sensitive |
| ENSG00000258673.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007260389 |
Sensitive |
| ENSG00000258938.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032311199 |
Sensitive |
| ENSG00000258940.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046571336 |
Sensitive |
| ENSG00000259081.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025134089 |
Sensitive |
| ENSG00000259244.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023851734 |
Sensitive |
| ENSG00000259372.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04850281 |
Sensitive |
| ENSG00000259424.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036818728 |
Sensitive |
| ENSG00000259475.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016410515 |
Sensitive |
| ENSG00000259561.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011329384 |
Sensitive |
| ENSG00000259774.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029256908 |
Sensitive |
| ENSG00000259792.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036729009 |
Sensitive |
| ENSG00000259843.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034170618 |
Sensitive |
| ENSG00000260077.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027249952 |
Sensitive |
| ENSG00000260378.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000265156 |
Sensitive |
| ENSG00000260641.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049154423 |
Sensitive |
| ENSG00000260766.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007280256 |
Sensitive |
| ENSG00000260953.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039585946 |
Sensitive |
| ENSG00000261024.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004062315 |
Sensitive |
| ENSG00000261305.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042573991 |
Sensitive |
| ENSG00000261512.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030713917 |
Sensitive |
| ENSG00000261582.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041918806 |
Sensitive |
| ENSG00000261597.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015300946 |
Sensitive |
| ENSG00000261616.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045576283 |
Sensitive |
| ENSG00000261645.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019993793 |
Sensitive |
| ENSG00000261654.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002221489 |
Sensitive |
| ENSG00000261829.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010658184 |
Sensitive |
| ENSG00000262094.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018231337 |
Sensitive |
| ENSG00000262165.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04208233 |
Sensitive |
| ENSG00000262580.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040743201 |
Sensitive |
| ENSG00000263293.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00644254 |
Sensitive |
| ENSG00000264167.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016126246 |
Sensitive |
| ENSG00000264520.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007536715 |
Sensitive |
| ENSG00000264932.2 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043247688 |
Sensitive |
| ENSG00000265205.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009539959 |
Sensitive |
| ENSG00000265692.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02844779 |
Sensitive |
| ENSG00000266340.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012587471 |
Sensitive |
| ENSG00000266903.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048799463 |
Sensitive |
| ENSG00000267169.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037474226 |
Sensitive |
| ENSG00000267278.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023293588 |
Sensitive |
| ENSG00000267651.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003558469 |
Sensitive |
| ENSG00000269489.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017646595 |
Sensitive |
| ENSG00000270157.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0335412 |
Sensitive |
| ENSG00000270949.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022861818 |
Sensitive |
| ENSG00000271020.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020763847 |
Sensitive |
| ENSG00000272003.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003719417 |
Sensitive |
| ENSG00000272072.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032412814 |
Sensitive |
| ENSG00000272102.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048611866 |
Sensitive |
| ENSG00000272172.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002353562 |
Sensitive |
| ENSG00000272236.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045075742 |
Sensitive |
| ENSG00000272275.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014705275 |
Sensitive |
| ENSG00000272341.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002712934 |
Sensitive |
| ENSG00000272732.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044929269 |
Sensitive |
| ENSG00000272782.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048582018 |
Sensitive |
| ENSG00000272824.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041908906 |
Sensitive |
| ENSG00000272849.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000470911 |
Sensitive |
| ENSG00000272949.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011864044 |
Sensitive |
| ENSG00000272979.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003394566 |
Sensitive |
| ENSG00000272995.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049713151 |
Sensitive |
| ENSG00000273014.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031928888 |
Sensitive |
| ENSG00000273027.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025125491 |
Sensitive |
| ENSG00000273033.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006774028 |
Sensitive |
| ENSG00000273038.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01879918 |
Sensitive |
| ENSG00000273142.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001158221 |
Sensitive |
| ENSG00000273174.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045594445 |
Sensitive |
| ENSG00000273305.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004188984 |
Sensitive |
| ENSG00000273355.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047629422 |
Sensitive |
| ENSG00000273356.1 |
Gemcitabine |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043106647 |
Sensitive |
| ENSG00000203356.2 |
Gemcitabine |
Esophageal cancer |
0.020561102 |
Sensitive |
| ENSG00000214922.5 |
Gemcitabine |
Esophageal cancer |
0.049121894 |
Sensitive |
| ENSG00000225302.1 |
Gemcitabine |
Esophageal cancer |
0.032818493 |
Sensitive |
| ENSG00000225439.2 |
Gemcitabine |
Esophageal cancer |
0.023526136 |
Sensitive |
| ENSG00000225793.2 |
Gemcitabine |
Esophageal cancer |
0.03470578 |
Sensitive |
| ENSG00000226876.2 |
Gemcitabine |
Esophageal cancer |
0.037489644 |
Sensitive |
| ENSG00000227589.1 |
Gemcitabine |
Esophageal cancer |
0.020383145 |
Sensitive |
| ENSG00000227617.4 |
Gemcitabine |
Esophageal cancer |
0.038182379 |
Sensitive |
| ENSG00000228140.1 |
Gemcitabine |
Esophageal cancer |
0.037946261 |
Sensitive |
| ENSG00000229841.1 |
Gemcitabine |
Esophageal cancer |
0.045296544 |
Sensitive |
| ENSG00000231329.3 |
Gemcitabine |
Esophageal cancer |
0.046984434 |
Sensitive |
| ENSG00000232229.1 |
Gemcitabine |
Esophageal cancer |
0.048212137 |
Sensitive |
| ENSG00000232878.1 |
Gemcitabine |
Esophageal cancer |
0.004069548 |
Sensitive |
| ENSG00000233296.1 |
Gemcitabine |
Esophageal cancer |
0.00060897 |
Sensitive |
| ENSG00000233355.2 |
Gemcitabine |
Esophageal cancer |
0.035196764 |
Sensitive |
| ENSG00000234076.1 |
Gemcitabine |
Esophageal cancer |
0.020558182 |
Sensitive |
| ENSG00000235298.1 |
Gemcitabine |
Esophageal cancer |
0.031721793 |
Sensitive |
| ENSG00000235740.1 |
Gemcitabine |
Esophageal cancer |
0.04317389 |
Sensitive |
| ENSG00000236337.1 |
Gemcitabine |
Esophageal cancer |
0.049774336 |
Sensitive |
| ENSG00000236643.1 |
Gemcitabine |
Esophageal cancer |
0.03285166 |
Sensitive |
| ENSG00000237073.1 |
Gemcitabine |
Esophageal cancer |
0.02702746 |
Sensitive |
| ENSG00000237853.2 |
Gemcitabine |
Esophageal cancer |
0.007603401 |
Sensitive |
| ENSG00000240549.2 |
Gemcitabine |
Esophageal cancer |
0.008374276 |
Sensitive |
| ENSG00000244332.1 |
Gemcitabine |
Esophageal cancer |
0.042790571 |
Sensitive |
| ENSG00000249345.2 |
Gemcitabine |
Esophageal cancer |
0.039631006 |
Sensitive |
| ENSG00000249364.1 |
Gemcitabine |
Esophageal cancer |
0.048921736 |
Sensitive |
| ENSG00000250999.1 |
Gemcitabine |
Esophageal cancer |
0.002824329 |
Sensitive |
| ENSG00000253880.1 |
Gemcitabine |
Esophageal cancer |
0.032741519 |
Sensitive |
| ENSG00000254006.1 |
Gemcitabine |
Esophageal cancer |
0.02422868 |
Sensitive |
| ENSG00000255308.1 |
Gemcitabine |
Esophageal cancer |
0.010626668 |
Sensitive |
| ENSG00000255354.1 |
Gemcitabine |
Esophageal cancer |
0.036175311 |
Sensitive |
| ENSG00000256448.1 |
Gemcitabine |
Esophageal cancer |
0.019185163 |
Sensitive |
| ENSG00000257222.1 |
Gemcitabine |
Esophageal cancer |
0.001818888 |
Sensitive |
| ENSG00000258667.1 |
Gemcitabine |
Esophageal cancer |
0.018898624 |
Sensitive |
| ENSG00000258752.1 |
Gemcitabine |
Esophageal cancer |
0.047091674 |
Sensitive |
| ENSG00000259418.1 |
Gemcitabine |
Esophageal cancer |
0.041754497 |
Sensitive |
| ENSG00000259521.1 |
Gemcitabine |
Esophageal cancer |
0.036458901 |
Sensitive |
| ENSG00000259711.1 |
Gemcitabine |
Esophageal cancer |
0.006853762 |
Sensitive |
| ENSG00000259735.1 |
Gemcitabine |
Esophageal cancer |
0.022690211 |
Sensitive |
| ENSG00000260095.1 |
Gemcitabine |
Esophageal cancer |
0.034165802 |
Sensitive |
| ENSG00000260787.1 |
Gemcitabine |
Esophageal cancer |
0.034550951 |
Sensitive |
| ENSG00000260830.1 |
Gemcitabine |
Esophageal cancer |
0.04267349 |
Sensitive |
| ENSG00000261101.1 |
Gemcitabine |
Esophageal cancer |
0.027728988 |
Sensitive |
| ENSG00000261250.1 |
Gemcitabine |
Esophageal cancer |
0.017368595 |
Sensitive |
| ENSG00000261469.1 |
Gemcitabine |
Esophageal cancer |
0.005138982 |
Sensitive |
| ENSG00000261823.1 |
Gemcitabine |
Esophageal cancer |
0.020138653 |
Sensitive |
| ENSG00000263893.2 |
Gemcitabine |
Esophageal cancer |
0.004856551 |
Sensitive |
| ENSG00000264458.1 |
Gemcitabine |
Esophageal cancer |
0.041271123 |
Sensitive |
| ENSG00000267640.1 |
Gemcitabine |
Esophageal cancer |
0.032982998 |
Sensitive |
| ENSG00000268655.1 |
Gemcitabine |
Esophageal cancer |
0.0187822 |
Sensitive |
| ENSG00000269086.2 |
Gemcitabine |
Esophageal cancer |
0.029720664 |
Sensitive |
| ENSG00000270562.1 |
Gemcitabine |
Esophageal cancer |
0.024196455 |
Sensitive |
| ENSG00000271109.1 |
Gemcitabine |
Esophageal cancer |
0.028924414 |
Sensitive |
| ENSG00000272795.1 |
Gemcitabine |
Esophageal cancer |
0.010515027 |
Sensitive |
| ENSG00000273456.1 |
Gemcitabine |
Esophageal cancer |
0.01346711 |
Sensitive |
| ENSG00000170846.11 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.029254052 |
Sensitive |
| ENSG00000179743.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.012864059 |
Sensitive |
| ENSG00000182376.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.032662737 |
Sensitive |
| ENSG00000203499.6 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.047713317 |
Sensitive |
| ENSG00000205037.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.018498041 |
Sensitive |
| ENSG00000214347.5 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.031606998 |
Sensitive |
| ENSG00000215159.3 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.015213487 |
Sensitive |
| ENSG00000224020.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.038866103 |
Sensitive |
| ENSG00000224023.6 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.044317878 |
Sensitive |
| ENSG00000224043.3 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.001838113 |
Sensitive |
| ENSG00000224358.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.046574727 |
Sensitive |
| ENSG00000225057.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.035615313 |
Sensitive |
| ENSG00000225172.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.023384446 |
Sensitive |
| ENSG00000225393.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.039440046 |
Sensitive |
| ENSG00000225703.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.048587762 |
Sensitive |
| ENSG00000225767.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.020037006 |
Sensitive |
| ENSG00000225953.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.044453109 |
Sensitive |
| ENSG00000226266.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.010090423 |
Sensitive |
| ENSG00000226281.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.041882403 |
Sensitive |
| ENSG00000226920.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.035646969 |
Sensitive |
| ENSG00000226950.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.007411024 |
Sensitive |
| ENSG00000227145.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.047522286 |
Sensitive |
| ENSG00000227630.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.041305695 |
Sensitive |
| ENSG00000227848.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.048070203 |
Sensitive |
| ENSG00000227953.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.029977783 |
Sensitive |
| ENSG00000227963.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.011051052 |
Sensitive |
| ENSG00000228288.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.035006729 |
Sensitive |
| ENSG00000228323.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.013958907 |
Sensitive |
| ENSG00000228817.3 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.042096715 |
Sensitive |
| ENSG00000229525.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.043043421 |
Sensitive |
| ENSG00000230061.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.037375536 |
Sensitive |
| ENSG00000230925.3 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.006362291 |
Sensitive |
| ENSG00000231393.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.016466317 |
Sensitive |
| ENSG00000231652.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.017204033 |
Sensitive |
| ENSG00000231871.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.027241937 |
Sensitive |
| ENSG00000231903.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.034055074 |
Sensitive |
| ENSG00000232648.3 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.017442254 |
Sensitive |
| ENSG00000232656.3 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.020827321 |
Sensitive |
| ENSG00000232969.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.021348502 |
Sensitive |
| ENSG00000233220.3 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.033440329 |
Sensitive |
| ENSG00000234084.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.047893866 |
Sensitive |
| ENSG00000234915.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.032520629 |
Sensitive |
| ENSG00000235096.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.046351429 |
Sensitive |
| ENSG00000236545.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.008942787 |
Sensitive |
| ENSG00000237934.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.041277052 |
Sensitive |
| ENSG00000237945.3 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.032752217 |
Sensitive |
| ENSG00000238057.4 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.022092101 |
Sensitive |
| ENSG00000238287.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.031370162 |
Sensitive |
| ENSG00000239415.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.033339136 |
Sensitive |
| ENSG00000241219.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.019002947 |
Sensitive |
| ENSG00000242094.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.036279511 |
Sensitive |
| ENSG00000242474.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.035946892 |
Sensitive |
| ENSG00000243533.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.028051176 |
Sensitive |
| ENSG00000244203.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.033684238 |
Sensitive |
| ENSG00000244459.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.043686251 |
Sensitive |
| ENSG00000246174.3 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.038674735 |
Sensitive |
| ENSG00000248019.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.022342947 |
Sensitive |
| ENSG00000248668.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.038306829 |
Sensitive |
| ENSG00000248714.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.034688833 |
Sensitive |
| ENSG00000248758.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.038665164 |
Sensitive |
| ENSG00000248925.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.043069122 |
Sensitive |
| ENSG00000249487.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.016992014 |
Sensitive |
| ENSG00000249684.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.017315363 |
Sensitive |
| ENSG00000250075.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.030696092 |
Sensitive |
| ENSG00000250081.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.040286982 |
Sensitive |
| ENSG00000250132.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.019457346 |
Sensitive |
| ENSG00000250282.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.023220299 |
Sensitive |
| ENSG00000251323.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.022539535 |
Sensitive |
| ENSG00000251580.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.032969983 |
Sensitive |
| ENSG00000253708.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.035676092 |
Sensitive |
| ENSG00000253737.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.049297583 |
Sensitive |
| ENSG00000253893.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.049312901 |
Sensitive |
| ENSG00000254389.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.035804461 |
Sensitive |
| ENSG00000254691.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.004211889 |
Sensitive |
| ENSG00000254869.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.032584941 |
Sensitive |
| ENSG00000255094.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.043990571 |
Sensitive |
| ENSG00000255650.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.005559797 |
Sensitive |
| ENSG00000256481.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.034286975 |
Sensitive |
| ENSG00000257167.2 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.012320596 |
Sensitive |
| ENSG00000257698.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.015526303 |
Sensitive |
| ENSG00000258454.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.018422885 |
Sensitive |
| ENSG00000259418.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.036754831 |
Sensitive |
| ENSG00000259804.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.031684121 |
Sensitive |
| ENSG00000260022.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.013221767 |
Sensitive |
| ENSG00000260269.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.02425078 |
Sensitive |
| ENSG00000260296.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.027937668 |
Sensitive |
| ENSG00000260417.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.041749381 |
Sensitive |
| ENSG00000260423.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.044068796 |
Sensitive |
| ENSG00000260515.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.018107707 |
Sensitive |
| ENSG00000260604.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.037844916 |
Sensitive |
| ENSG00000260936.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.011329441 |
Sensitive |
| ENSG00000260973.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.025448511 |
Sensitive |
| ENSG00000261372.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.042035134 |
Sensitive |
| ENSG00000261428.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.022465551 |
Sensitive |
| ENSG00000261430.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.02742147 |
Sensitive |
| ENSG00000261697.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.034563851 |
Sensitive |
| ENSG00000262410.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.019702934 |
Sensitive |
| ENSG00000263657.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.042576085 |
Sensitive |
| ENSG00000264207.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.023933329 |
Sensitive |
| ENSG00000264608.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.047309641 |
Sensitive |
| ENSG00000264829.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.03630707 |
Sensitive |
| ENSG00000265334.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.02956387 |
Sensitive |
| ENSG00000265987.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.016373058 |
Sensitive |
| ENSG00000266445.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.021096035 |
Sensitive |
| ENSG00000266801.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.032395221 |
Sensitive |
| ENSG00000267136.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.013691219 |
Sensitive |
| ENSG00000267141.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.027408078 |
Sensitive |
| ENSG00000267152.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.005258094 |
Sensitive |
| ENSG00000267366.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.008310954 |
Sensitive |
| ENSG00000267655.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.005539911 |
Sensitive |
| ENSG00000267702.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.00138087 |
Sensitive |
| ENSG00000268945.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.004826611 |
Sensitive |
| ENSG00000269194.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.020359477 |
Sensitive |
| ENSG00000269951.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.033943796 |
Sensitive |
| ENSG00000270072.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.024428736 |
Sensitive |
| ENSG00000270145.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.015665159 |
Sensitive |
| ENSG00000270557.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.007882344 |
Sensitive |
| ENSG00000270828.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.025695785 |
Sensitive |
| ENSG00000270951.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.007492563 |
Sensitive |
| ENSG00000271270.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.006918088 |
Sensitive |
| ENSG00000271367.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.045181208 |
Sensitive |
| ENSG00000271576.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.044871685 |
Sensitive |
| ENSG00000271631.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.043466913 |
Sensitive |
| ENSG00000271757.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.044666849 |
Sensitive |
| ENSG00000271869.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.01816065 |
Sensitive |
| ENSG00000271921.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.045815485 |
Sensitive |
| ENSG00000271948.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.001261802 |
Sensitive |
| ENSG00000271998.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.020017309 |
Sensitive |
| ENSG00000272221.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.021704253 |
Sensitive |
| ENSG00000272255.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.015466387 |
Sensitive |
| ENSG00000272301.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.007705739 |
Sensitive |
| ENSG00000272365.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.030025273 |
Sensitive |
| ENSG00000272373.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.011772955 |
Sensitive |
| ENSG00000272375.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.010060867 |
Sensitive |
| ENSG00000272420.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.039359772 |
Sensitive |
| ENSG00000272426.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.043456851 |
Sensitive |
| ENSG00000272452.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.016438756 |
Sensitive |
| ENSG00000272524.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.035319932 |
Sensitive |
| ENSG00000272556.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.042116079 |
Sensitive |
| ENSG00000272562.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.031416198 |
Sensitive |
| ENSG00000272667.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.012086396 |
Sensitive |
| ENSG00000272746.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.008104846 |
Sensitive |
| ENSG00000272754.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.025098521 |
Sensitive |
| ENSG00000272777.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.016422907 |
Sensitive |
| ENSG00000272795.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.041057397 |
Sensitive |
| ENSG00000272800.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.022260319 |
Sensitive |
| ENSG00000272810.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.040606439 |
Sensitive |
| ENSG00000273066.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.047838571 |
Sensitive |
| ENSG00000273075.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.023962638 |
Sensitive |
| ENSG00000273091.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.008593015 |
Sensitive |
| ENSG00000273156.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.049514998 |
Sensitive |
| ENSG00000273402.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.026460974 |
Sensitive |
| ENSG00000273487.1 |
Gemcitabine |
Chronic Lymphocytic Leukemia |
0.027810451 |
Sensitive |
| ENSG00000175701.6 |
Gemcitabine |
Brain lower grade glioma |
0.024858383 |
Sensitive |
| ENSG00000177337.3 |
Gemcitabine |
Brain lower grade glioma |
0.04836535 |
Sensitive |
| ENSG00000204792.2 |
Gemcitabine |
Brain lower grade glioma |
0.038721952 |
Sensitive |
| ENSG00000215068.3 |
Gemcitabine |
Brain lower grade glioma |
0.04055968 |
Sensitive |
| ENSG00000215863.2 |
Gemcitabine |
Brain lower grade glioma |
0.017751512 |
Sensitive |
| ENSG00000223477.3 |
Gemcitabine |
Brain lower grade glioma |
0.046116006 |
Sensitive |
| ENSG00000223485.1 |
Gemcitabine |
Brain lower grade glioma |
0.034102467 |
Sensitive |
| ENSG00000223685.1 |
Gemcitabine |
Brain lower grade glioma |
0.045518468 |
Sensitive |
| ENSG00000223779.4 |
Gemcitabine |
Brain lower grade glioma |
0.04298766 |
Sensitive |
| ENSG00000223804.1 |
Gemcitabine |
Brain lower grade glioma |
0.041689604 |
Sensitive |
| ENSG00000223806.3 |
Gemcitabine |
Brain lower grade glioma |
0.045843462 |
Sensitive |
| ENSG00000224818.1 |
Gemcitabine |
Brain lower grade glioma |
0.027726631 |
Sensitive |
| ENSG00000224932.1 |
Gemcitabine |
Brain lower grade glioma |
0.049652801 |
Sensitive |
| ENSG00000225205.1 |
Gemcitabine |
Brain lower grade glioma |
0.000544281 |
Sensitive |
| ENSG00000225676.1 |
Gemcitabine |
Brain lower grade glioma |
0.027963346 |
Sensitive |
| ENSG00000225953.2 |
Gemcitabine |
Brain lower grade glioma |
0.000892774 |
Sensitive |
| ENSG00000226047.1 |
Gemcitabine |
Brain lower grade glioma |
0.000924108 |
Sensitive |
| ENSG00000226193.1 |
Gemcitabine |
Brain lower grade glioma |
0.046282795 |
Sensitive |
| ENSG00000226251.1 |
Gemcitabine |
Brain lower grade glioma |
0.025890945 |
Sensitive |
| ENSG00000226334.1 |
Gemcitabine |
Brain lower grade glioma |
0.018117681 |
Sensitive |
| ENSG00000227053.1 |
Gemcitabine |
Brain lower grade glioma |
0.009322911 |
Sensitive |
| ENSG00000227070.1 |
Gemcitabine |
Brain lower grade glioma |
0.035026737 |
Sensitive |
| ENSG00000227959.1 |
Gemcitabine |
Brain lower grade glioma |
0.04293191 |
Sensitive |
| ENSG00000229043.2 |
Gemcitabine |
Brain lower grade glioma |
0.040773074 |
Sensitive |
| ENSG00000229162.1 |
Gemcitabine |
Brain lower grade glioma |
0.034808729 |
Sensitive |
| ENSG00000229952.1 |
Gemcitabine |
Brain lower grade glioma |
0.039542047 |
Sensitive |
| ENSG00000230102.3 |
Gemcitabine |
Brain lower grade glioma |
0.000124753 |
Sensitive |
| ENSG00000230133.1 |
Gemcitabine |
Brain lower grade glioma |
0.030630756 |
Sensitive |
| ENSG00000230479.1 |
Gemcitabine |
Brain lower grade glioma |
0.039437528 |
Sensitive |
| ENSG00000230542.1 |
Gemcitabine |
Brain lower grade glioma |
0.040588145 |
Sensitive |
| ENSG00000230937.5 |
Gemcitabine |
Brain lower grade glioma |
0.035888237 |
Sensitive |
| ENSG00000231187.2 |
Gemcitabine |
Brain lower grade glioma |
0.044563568 |
Sensitive |
| ENSG00000231507.1 |
Gemcitabine |
Brain lower grade glioma |
0.034250969 |
Sensitive |
| ENSG00000231770.1 |
Gemcitabine |
Brain lower grade glioma |
0.03917219 |
Sensitive |
| ENSG00000231890.3 |
Gemcitabine |
Brain lower grade glioma |
0.045191468 |
Sensitive |
| ENSG00000231908.1 |
Gemcitabine |
Brain lower grade glioma |
0.008548543 |
Sensitive |
| ENSG00000232325.3 |
Gemcitabine |
Brain lower grade glioma |
0.020994256 |
Sensitive |
| ENSG00000232453.1 |
Gemcitabine |
Brain lower grade glioma |
0.041135532 |
Sensitive |
| ENSG00000233101.6 |
Gemcitabine |
Brain lower grade glioma |
0.016534755 |
Sensitive |
| ENSG00000233368.2 |
Gemcitabine |
Brain lower grade glioma |
0.037912219 |
Sensitive |
| ENSG00000233521.1 |
Gemcitabine |
Brain lower grade glioma |
0.023211039 |
Sensitive |
| ENSG00000233593.2 |
Gemcitabine |
Brain lower grade glioma |
0.031880148 |
Sensitive |
| ENSG00000233818.1 |
Gemcitabine |
Brain lower grade glioma |
0.030297963 |
Sensitive |
| ENSG00000233901.1 |
Gemcitabine |
Brain lower grade glioma |
0.049709099 |
Sensitive |
| ENSG00000233903.2 |
Gemcitabine |
Brain lower grade glioma |
0.044399573 |
Sensitive |
| ENSG00000233912.1 |
Gemcitabine |
Brain lower grade glioma |
0.01708031 |
Sensitive |
| ENSG00000234232.2 |
Gemcitabine |
Brain lower grade glioma |
0.017253035 |
Sensitive |
| ENSG00000234394.4 |
Gemcitabine |
Brain lower grade glioma |
0.042816096 |
Sensitive |
| ENSG00000234753.1 |
Gemcitabine |
Brain lower grade glioma |
0.00291653 |
Sensitive |
| ENSG00000234883.2 |
Gemcitabine |
Brain lower grade glioma |
0.017149299 |
Sensitive |
| ENSG00000235180.1 |
Gemcitabine |
Brain lower grade glioma |
0.026804556 |
Sensitive |
| ENSG00000235387.1 |
Gemcitabine |
Brain lower grade glioma |
0.000683297 |
Sensitive |
| ENSG00000235398.4 |
Gemcitabine |
Brain lower grade glioma |
0.043883073 |
Sensitive |
| ENSG00000235590.3 |
Gemcitabine |
Brain lower grade glioma |
0.047723323 |
Sensitive |
| ENSG00000235643.1 |
Gemcitabine |
Brain lower grade glioma |
0.039894712 |
Sensitive |
| ENSG00000235740.1 |
Gemcitabine |
Brain lower grade glioma |
0.043782536 |
Sensitive |
| ENSG00000235823.1 |
Gemcitabine |
Brain lower grade glioma |
0.022012994 |
Sensitive |
| ENSG00000236091.1 |
Gemcitabine |
Brain lower grade glioma |
0.022487335 |
Sensitive |
| ENSG00000236199.1 |
Gemcitabine |
Brain lower grade glioma |
0.043231915 |
Sensitive |
| ENSG00000236200.1 |
Gemcitabine |
Brain lower grade glioma |
0.004317606 |
Sensitive |
| ENSG00000236384.3 |
Gemcitabine |
Brain lower grade glioma |
0.030597253 |
Sensitive |
| ENSG00000236591.1 |
Gemcitabine |
Brain lower grade glioma |
0.036701807 |
Sensitive |
| ENSG00000236943.2 |
Gemcitabine |
Brain lower grade glioma |
0.042938868 |
Sensitive |
| ENSG00000237424.1 |
Gemcitabine |
Brain lower grade glioma |
0.00721865 |
Sensitive |
| ENSG00000237523.1 |
Gemcitabine |
Brain lower grade glioma |
0.011255112 |
Sensitive |
| ENSG00000237595.2 |
Gemcitabine |
Brain lower grade glioma |
0.013856425 |
Sensitive |
| ENSG00000237686.2 |
Gemcitabine |
Brain lower grade glioma |
0.04846092 |
Sensitive |
| ENSG00000239674.2 |
Gemcitabine |
Brain lower grade glioma |
0.02476723 |
Sensitive |
| ENSG00000242396.1 |
Gemcitabine |
Brain lower grade glioma |
0.030513968 |
Sensitive |
| ENSG00000243637.1 |
Gemcitabine |
Brain lower grade glioma |
0.029121289 |
Sensitive |
| ENSG00000244738.1 |
Gemcitabine |
Brain lower grade glioma |
0.020303955 |
Sensitive |
| ENSG00000245468.3 |
Gemcitabine |
Brain lower grade glioma |
0.040659176 |
Sensitive |
| ENSG00000247095.2 |
Gemcitabine |
Brain lower grade glioma |
0.006848178 |
Sensitive |
| ENSG00000247675.2 |
Gemcitabine |
Brain lower grade glioma |
0.019915281 |
Sensitive |
| ENSG00000248125.1 |
Gemcitabine |
Brain lower grade glioma |
0.043029954 |
Sensitive |
| ENSG00000249375.3 |
Gemcitabine |
Brain lower grade glioma |
0.041332289 |
Sensitive |
| ENSG00000249740.1 |
Gemcitabine |
Brain lower grade glioma |
0.036126299 |
Sensitive |
| ENSG00000250222.1 |
Gemcitabine |
Brain lower grade glioma |
0.00924754 |
Sensitive |
| ENSG00000251151.2 |
Gemcitabine |
Brain lower grade glioma |
0.045327235 |
Sensitive |
| ENSG00000251442.1 |
Gemcitabine |
Brain lower grade glioma |
0.028107116 |
Sensitive |
| ENSG00000253121.1 |
Gemcitabine |
Brain lower grade glioma |
0.010270747 |
Sensitive |
| ENSG00000253286.1 |
Gemcitabine |
Brain lower grade glioma |
0.006129551 |
Sensitive |
| ENSG00000253298.1 |
Gemcitabine |
Brain lower grade glioma |
0.000062 |
Sensitive |
| ENSG00000253669.3 |
Gemcitabine |
Brain lower grade glioma |
0.033014453 |
Sensitive |
| ENSG00000253736.1 |
Gemcitabine |
Brain lower grade glioma |
0.047956248 |
Sensitive |
| ENSG00000253917.3 |
Gemcitabine |
Brain lower grade glioma |
0.019013627 |
Sensitive |
| ENSG00000254480.1 |
Gemcitabine |
Brain lower grade glioma |
0.00482915 |
Sensitive |
| ENSG00000254639.1 |
Gemcitabine |
Brain lower grade glioma |
0.013229302 |
Sensitive |
| ENSG00000255276.1 |
Gemcitabine |
Brain lower grade glioma |
0.017680671 |
Sensitive |
| ENSG00000255867.1 |
Gemcitabine |
Brain lower grade glioma |
0.006213571 |
Sensitive |
| ENSG00000257261.1 |
Gemcitabine |
Brain lower grade glioma |
0.009907417 |
Sensitive |
| ENSG00000259230.1 |
Gemcitabine |
Brain lower grade glioma |
0.0481482 |
Sensitive |
| ENSG00000259245.1 |
Gemcitabine |
Brain lower grade glioma |
0.034391309 |
Sensitive |
| ENSG00000259771.1 |
Gemcitabine |
Brain lower grade glioma |
0.04974386 |
Sensitive |
| ENSG00000259942.1 |
Gemcitabine |
Brain lower grade glioma |
0.018117411 |
Sensitive |
| ENSG00000261238.1 |
Gemcitabine |
Brain lower grade glioma |
0.049863983 |
Sensitive |
| ENSG00000261488.1 |
Gemcitabine |
Brain lower grade glioma |
0.032151532 |
Sensitive |
| ENSG00000262089.1 |
Gemcitabine |
Brain lower grade glioma |
0.017696478 |
Sensitive |
| ENSG00000262136.1 |
Gemcitabine |
Brain lower grade glioma |
0.003994805 |
Sensitive |
| ENSG00000262823.1 |
Gemcitabine |
Brain lower grade glioma |
0.024103414 |
Sensitive |
| ENSG00000263105.1 |
Gemcitabine |
Brain lower grade glioma |
0.02765065 |
Sensitive |
| ENSG00000264188.1 |
Gemcitabine |
Brain lower grade glioma |
0.040518929 |
Sensitive |
| ENSG00000264456.1 |
Gemcitabine |
Brain lower grade glioma |
0.007575219 |
Sensitive |
| ENSG00000265458.1 |
Gemcitabine |
Brain lower grade glioma |
0.018651275 |
Sensitive |
| ENSG00000266283.1 |
Gemcitabine |
Brain lower grade glioma |
0.03887432 |
Sensitive |
| ENSG00000266397.1 |
Gemcitabine |
Brain lower grade glioma |
0.048800736 |
Sensitive |
| ENSG00000266947.1 |
Gemcitabine |
Brain lower grade glioma |
0.005724952 |
Sensitive |
| ENSG00000267449.1 |
Gemcitabine |
Brain lower grade glioma |
0.00046844 |
Sensitive |
| ENSG00000267547.1 |
Gemcitabine |
Brain lower grade glioma |
0.008735567 |
Sensitive |
| ENSG00000267711.1 |
Gemcitabine |
Brain lower grade glioma |
0.026979909 |
Sensitive |
| ENSG00000267745.1 |
Gemcitabine |
Brain lower grade glioma |
0.003138194 |
Sensitive |
| ENSG00000267939.1 |
Gemcitabine |
Brain lower grade glioma |
0.024320627 |
Sensitive |
| ENSG00000271857.1 |
Gemcitabine |
Brain lower grade glioma |
0.036526898 |
Sensitive |
| ENSG00000272004.1 |
Gemcitabine |
Brain lower grade glioma |
0.049350696 |
Sensitive |
| ENSG00000272221.1 |
Gemcitabine |
Brain lower grade glioma |
0.00554656 |
Sensitive |
| ENSG00000272226.1 |
Gemcitabine |
Brain lower grade glioma |
0.02439314 |
Sensitive |
| ENSG00000272366.1 |
Gemcitabine |
Brain lower grade glioma |
0.007066138 |
Sensitive |
| ENSG00000272369.1 |
Gemcitabine |
Brain lower grade glioma |
0.000341939 |
Sensitive |
| ENSG00000272382.1 |
Gemcitabine |
Brain lower grade glioma |
0.035293006 |
Sensitive |
| ENSG00000272709.1 |
Gemcitabine |
Brain lower grade glioma |
0.001659359 |
Sensitive |
| ENSG00000272755.1 |
Gemcitabine |
Brain lower grade glioma |
0.023945167 |
Sensitive |
| ENSG00000273027.1 |
Gemcitabine |
Brain lower grade glioma |
0.005695807 |
Sensitive |
| ENSG00000273117.1 |
Gemcitabine |
Brain lower grade glioma |
0.03355535 |
Sensitive |
| ENSG00000273406.1 |
Gemcitabine |
Brain lower grade glioma |
0.014582165 |
Sensitive |
| ENSG00000182404.6 |
Gemcitabine |
Lung squamous cell carcinoma |
0.008824375 |
Sensitive |
| ENSG00000182648.7 |
Gemcitabine |
Lung squamous cell carcinoma |
0.037471386 |
Sensitive |
| ENSG00000184274.3 |
Gemcitabine |
Lung squamous cell carcinoma |
0.021253537 |
Sensitive |
| ENSG00000197308.4 |
Gemcitabine |
Lung squamous cell carcinoma |
0.043506355 |
Sensitive |
| ENSG00000212930.3 |
Gemcitabine |
Lung squamous cell carcinoma |
0.038037047 |
Sensitive |
| ENSG00000214803.3 |
Gemcitabine |
Lung squamous cell carcinoma |
0.031233836 |
Sensitive |
| ENSG00000223759.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.008702805 |
Sensitive |
| ENSG00000224000.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.023480754 |
Sensitive |
| ENSG00000224574.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.01177319 |
Sensitive |
| ENSG00000224671.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.045410361 |
Sensitive |
| ENSG00000224764.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.02248265 |
Sensitive |
| ENSG00000225684.3 |
Gemcitabine |
Lung squamous cell carcinoma |
0.003009042 |
Sensitive |
| ENSG00000226067.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.006184046 |
Sensitive |
| ENSG00000226637.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.045452336 |
Sensitive |
| ENSG00000227678.3 |
Gemcitabine |
Lung squamous cell carcinoma |
0.014877672 |
Sensitive |
| ENSG00000227925.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.032153785 |
Sensitive |
| ENSG00000228322.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.034757993 |
Sensitive |
| ENSG00000228886.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.025927966 |
Sensitive |
| ENSG00000229563.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.021930971 |
Sensitive |
| ENSG00000229931.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.037778991 |
Sensitive |
| ENSG00000229953.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.016995994 |
Sensitive |
| ENSG00000230550.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.006723942 |
Sensitive |
| ENSG00000230815.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.03125177 |
Sensitive |
| ENSG00000231185.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.041931389 |
Sensitive |
| ENSG00000231528.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.002364829 |
Sensitive |
| ENSG00000231609.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.033046083 |
Sensitive |
| ENSG00000231646.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.035342213 |
Sensitive |
| ENSG00000232638.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.049561586 |
Sensitive |
| ENSG00000232935.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.035395049 |
Sensitive |
| ENSG00000233532.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.049904202 |
Sensitive |
| ENSG00000233776.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.032860875 |
Sensitive |
| ENSG00000234155.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.006048767 |
Sensitive |
| ENSG00000235298.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.038818211 |
Sensitive |
| ENSG00000235427.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.022585927 |
Sensitive |
| ENSG00000235724.4 |
Gemcitabine |
Lung squamous cell carcinoma |
0.048183274 |
Sensitive |
| ENSG00000235848.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.014554553 |
Sensitive |
| ENSG00000235884.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.02227121 |
Sensitive |
| ENSG00000235999.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.003824288 |
Sensitive |
| ENSG00000236098.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.024661845 |
Sensitive |
| ENSG00000236213.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.013505401 |
Sensitive |
| ENSG00000236921.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.047230509 |
Sensitive |
| ENSG00000236936.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.022125028 |
Sensitive |
| ENSG00000237476.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.029521605 |
Sensitive |
| ENSG00000238042.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.032213081 |
Sensitive |
| ENSG00000238160.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.014711455 |
Sensitive |
| ENSG00000238290.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.004797925 |
Sensitive |
| ENSG00000241985.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.015668728 |
Sensitive |
| ENSG00000242759.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.049363893 |
Sensitive |
| ENSG00000248132.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.049512619 |
Sensitive |
| ENSG00000248996.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.011324827 |
Sensitive |
| ENSG00000249328.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.042742235 |
Sensitive |
| ENSG00000249669.3 |
Gemcitabine |
Lung squamous cell carcinoma |
0.04224245 |
Sensitive |
| ENSG00000249942.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.043792114 |
Sensitive |
| ENSG00000250159.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.028411294 |
Sensitive |
| ENSG00000250608.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.037255674 |
Sensitive |
| ENSG00000250635.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.046709942 |
Sensitive |
| ENSG00000251003.3 |
Gemcitabine |
Lung squamous cell carcinoma |
0.046655044 |
Sensitive |
| ENSG00000253522.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.047364782 |
Sensitive |
| ENSG00000253526.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.03967821 |
Sensitive |
| ENSG00000254142.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.020668882 |
Sensitive |
| ENSG00000255476.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.01975912 |
Sensitive |
| ENSG00000256128.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.020933271 |
Sensitive |
| ENSG00000256268.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.007531313 |
Sensitive |
| ENSG00000257097.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.03403481 |
Sensitive |
| ENSG00000258400.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.026498028 |
Sensitive |
| ENSG00000258521.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.047446422 |
Sensitive |
| ENSG00000258537.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.047324387 |
Sensitive |
| ENSG00000258760.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.036466796 |
Sensitive |
| ENSG00000258902.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.046009979 |
Sensitive |
| ENSG00000258914.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.029341173 |
Sensitive |
| ENSG00000258929.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.026004933 |
Sensitive |
| ENSG00000259712.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.047268253 |
Sensitive |
| ENSG00000260088.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.045609056 |
Sensitive |
| ENSG00000260507.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.03479323 |
Sensitive |
| ENSG00000261519.2 |
Gemcitabine |
Lung squamous cell carcinoma |
0.003636163 |
Sensitive |
| ENSG00000261757.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.046157054 |
Sensitive |
| ENSG00000263293.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.034979092 |
Sensitive |
| ENSG00000263388.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.023546515 |
Sensitive |
| ENSG00000263745.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.019231486 |
Sensitive |
| ENSG00000264513.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.038824455 |
Sensitive |
| ENSG00000267375.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.010314759 |
Sensitive |
| ENSG00000269895.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.020318989 |
Sensitive |
| ENSG00000270069.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.012938828 |
Sensitive |
| ENSG00000271716.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.001361429 |
Sensitive |
| ENSG00000271857.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.049816703 |
Sensitive |
| ENSG00000272341.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.034699061 |
Sensitive |
| ENSG00000272346.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.016506059 |
Sensitive |
| ENSG00000272666.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.036822009 |
Sensitive |
| ENSG00000272808.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.048654696 |
Sensitive |
| ENSG00000273065.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.01524983 |
Sensitive |
| ENSG00000273272.1 |
Gemcitabine |
Lung squamous cell carcinoma |
0.041103207 |
Sensitive |
| ENSG00000178803.6 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.037395841 |
Sensitive |
| ENSG00000203645.2 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.030285022 |
Sensitive |
| ENSG00000214049.6 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.038029717 |
Sensitive |
| ENSG00000215304.3 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.017317027 |
Sensitive |
| ENSG00000225963.3 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.043854707 |
Sensitive |
| ENSG00000226533.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.014277428 |
Sensitive |
| ENSG00000227071.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.044919547 |
Sensitive |
| ENSG00000227543.3 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.005352055 |
Sensitive |
| ENSG00000227591.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.009260459 |
Sensitive |
| ENSG00000228470.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.003569684 |
Sensitive |
| ENSG00000230438.5 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.006735489 |
Sensitive |
| ENSG00000230730.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.007501188 |
Sensitive |
| ENSG00000230812.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.040063867 |
Sensitive |
| ENSG00000231201.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.005481524 |
Sensitive |
| ENSG00000231742.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.040273769 |
Sensitive |
| ENSG00000233250.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.009962957 |
Sensitive |
| ENSG00000233593.2 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.01395481 |
Sensitive |
| ENSG00000233757.2 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.025723163 |
Sensitive |
| ENSG00000236404.4 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.002977072 |
Sensitive |
| ENSG00000237605.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.041177675 |
Sensitive |
| ENSG00000241732.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.000895772 |
Sensitive |
| ENSG00000243960.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.028227383 |
Sensitive |
| ENSG00000249310.2 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.018825758 |
Sensitive |
| ENSG00000250116.2 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.03194391 |
Sensitive |
| ENSG00000251161.2 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.020161263 |
Sensitive |
| ENSG00000251556.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.026502084 |
Sensitive |
| ENSG00000253824.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.021921589 |
Sensitive |
| ENSG00000254602.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.035191153 |
Sensitive |
| ENSG00000255002.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.032625455 |
Sensitive |
| ENSG00000256802.2 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.010159584 |
Sensitive |
| ENSG00000257527.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.023224216 |
Sensitive |
| ENSG00000258323.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.026410906 |
Sensitive |
| ENSG00000259070.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.012619953 |
Sensitive |
| ENSG00000259342.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.008590208 |
Sensitive |
| ENSG00000259345.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.031881131 |
Sensitive |
| ENSG00000259354.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.046601029 |
Sensitive |
| ENSG00000259521.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.031942187 |
Sensitive |
| ENSG00000259623.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.006132056 |
Sensitive |
| ENSG00000260060.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.011633258 |
Sensitive |
| ENSG00000260372.2 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.019624526 |
Sensitive |
| ENSG00000260400.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.017068494 |
Sensitive |
| ENSG00000260558.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.019991864 |
Sensitive |
| ENSG00000260585.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.019084293 |
Sensitive |
| ENSG00000260814.2 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.043980119 |
Sensitive |
| ENSG00000261662.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.015582759 |
Sensitive |
| ENSG00000262837.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.045204257 |
Sensitive |
| ENSG00000263393.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.026054967 |
Sensitive |
| ENSG00000263731.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.02862396 |
Sensitive |
| ENSG00000263859.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.010880139 |
Sensitive |
| ENSG00000264608.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.00588886 |
Sensitive |
| ENSG00000264968.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.030498385 |
Sensitive |
| ENSG00000265008.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.036961139 |
Sensitive |
| ENSG00000265791.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.004725651 |
Sensitive |
| ENSG00000265992.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.047943466 |
Sensitive |
| ENSG00000266644.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.046665961 |
Sensitive |
| ENSG00000267308.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.025780219 |
Sensitive |
| ENSG00000267504.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.019783303 |
Sensitive |
| ENSG00000267751.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.031680786 |
Sensitive |
| ENSG00000268549.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.012530904 |
Sensitive |
| ENSG00000270109.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.015838442 |
Sensitive |
| ENSG00000270246.2 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.010165993 |
Sensitive |
| ENSG00000270760.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.003852652 |
Sensitive |
| ENSG00000272003.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.025069455 |
Sensitive |
| ENSG00000272009.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.014913863 |
Sensitive |
| ENSG00000272191.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.037788297 |
Sensitive |
| ENSG00000272217.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.047712285 |
Sensitive |
| ENSG00000272682.1 |
Gemcitabine |
Pancreatic adenocarcinoma |
0.011195907 |
Sensitive |
| ENSG00000212163.2 |
Gemcitabine |
Sarcoma |
0.01906298 |
Sensitive |
| ENSG00000223528.3 |
Gemcitabine |
Sarcoma |
0.042299144 |
Sensitive |
| ENSG00000225113.1 |
Gemcitabine |
Sarcoma |
0.013305706 |
Sensitive |
| ENSG00000225489.2 |
Gemcitabine |
Sarcoma |
0.005923481 |
Sensitive |
| ENSG00000227372.6 |
Gemcitabine |
Sarcoma |
0.044358176 |
Sensitive |
| ENSG00000228126.1 |
Gemcitabine |
Sarcoma |
0.017469405 |
Sensitive |
| ENSG00000229848.1 |
Gemcitabine |
Sarcoma |
0.031620023 |
Sensitive |
| ENSG00000231611.1 |
Gemcitabine |
Sarcoma |
0.032500271 |
Sensitive |
| ENSG00000232956.4 |
Gemcitabine |
Sarcoma |
0.0303452 |
Sensitive |
| ENSG00000234678.1 |
Gemcitabine |
Sarcoma |
0.038864465 |
Sensitive |
| ENSG00000236140.1 |
Gemcitabine |
Sarcoma |
0.044110621 |
Sensitive |
| ENSG00000236901.3 |
Gemcitabine |
Sarcoma |
0.046867003 |
Sensitive |
| ENSG00000237646.1 |
Gemcitabine |
Sarcoma |
0.020128045 |
Sensitive |
| ENSG00000246250.2 |
Gemcitabine |
Sarcoma |
0.014934156 |
Sensitive |
| ENSG00000247679.2 |
Gemcitabine |
Sarcoma |
0.010506733 |
Sensitive |
| ENSG00000248175.1 |
Gemcitabine |
Sarcoma |
0.047317873 |
Sensitive |
| ENSG00000249602.1 |
Gemcitabine |
Sarcoma |
0.042661361 |
Sensitive |
| ENSG00000255236.2 |
Gemcitabine |
Sarcoma |
0.038095908 |
Sensitive |
| ENSG00000256802.2 |
Gemcitabine |
Sarcoma |
0.009084455 |
Sensitive |
| ENSG00000257151.1 |
Gemcitabine |
Sarcoma |
0.019008245 |
Sensitive |
| ENSG00000257497.1 |
Gemcitabine |
Sarcoma |
0.000459532 |
Sensitive |
| ENSG00000259163.1 |
Gemcitabine |
Sarcoma |
0.039382142 |
Sensitive |
| ENSG00000259865.1 |
Gemcitabine |
Sarcoma |
0.031654304 |
Sensitive |
| ENSG00000260269.1 |
Gemcitabine |
Sarcoma |
0.020048049 |
Sensitive |
| ENSG00000260351.1 |
Gemcitabine |
Sarcoma |
0.045873492 |
Sensitive |
| ENSG00000260388.1 |
Gemcitabine |
Sarcoma |
0.036157399 |
Sensitive |
| ENSG00000260905.1 |
Gemcitabine |
Sarcoma |
0.035460834 |
Sensitive |
| ENSG00000260938.1 |
Gemcitabine |
Sarcoma |
0.033292575 |
Sensitive |
| ENSG00000261101.1 |
Gemcitabine |
Sarcoma |
0.029835731 |
Sensitive |
| ENSG00000261889.1 |
Gemcitabine |
Sarcoma |
0.018776909 |
Sensitive |
| ENSG00000262692.1 |
Gemcitabine |
Sarcoma |
0.021065624 |
Sensitive |
| ENSG00000262766.1 |
Gemcitabine |
Sarcoma |
0.001888463 |
Sensitive |
| ENSG00000264112.1 |
Gemcitabine |
Sarcoma |
0.006973178 |
Sensitive |
| ENSG00000265478.1 |
Gemcitabine |
Sarcoma |
0.017483905 |
Sensitive |
| ENSG00000267138.1 |
Gemcitabine |
Sarcoma |
0.004633029 |
Sensitive |
| ENSG00000267505.1 |
Gemcitabine |
Sarcoma |
0.015755746 |
Sensitive |
| ENSG00000267765.1 |
Gemcitabine |
Sarcoma |
0.011676854 |
Sensitive |
| ENSG00000268945.1 |
Gemcitabine |
Sarcoma |
0.004587444 |
Sensitive |
| ENSG00000269473.1 |
Gemcitabine |
Sarcoma |
0.021869795 |
Sensitive |
| ENSG00000269947.1 |
Gemcitabine |
Sarcoma |
0.013094028 |
Sensitive |
| ENSG00000269979.1 |
Gemcitabine |
Sarcoma |
0.045931731 |
Sensitive |
| ENSG00000271789.1 |
Gemcitabine |
Sarcoma |
0.04467746 |
Sensitive |
| ENSG00000273102.1 |
Gemcitabine |
Sarcoma |
0.026077695 |
Sensitive |
| ENSG00000117242.7 |
Gemcitabine |
Skin cutaneous melanoma |
0.047736699 |
Sensitive |
| ENSG00000180139.10 |
Gemcitabine |
Skin cutaneous melanoma |
0.03819528 |
Sensitive |
| ENSG00000203808.6 |
Gemcitabine |
Skin cutaneous melanoma |
0.012706232 |
Sensitive |
| ENSG00000205037.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.001913398 |
Sensitive |
| ENSG00000224700.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.008731307 |
Sensitive |
| ENSG00000225057.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.012827415 |
Sensitive |
| ENSG00000225880.4 |
Gemcitabine |
Skin cutaneous melanoma |
0.002370854 |
Sensitive |
| ENSG00000225914.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.035781997 |
Sensitive |
| ENSG00000225973.3 |
Gemcitabine |
Skin cutaneous melanoma |
0.01446309 |
Sensitive |
| ENSG00000226824.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.012234448 |
Sensitive |
| ENSG00000227117.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.035112892 |
Sensitive |
| ENSG00000228261.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.047024901 |
Sensitive |
| ENSG00000228350.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.013137229 |
Sensitive |
| ENSG00000228436.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.028063461 |
Sensitive |
| ENSG00000228554.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.035224056 |
Sensitive |
| ENSG00000228838.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.025875714 |
Sensitive |
| ENSG00000229214.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.022636215 |
Sensitive |
| ENSG00000232085.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.019787857 |
Sensitive |
| ENSG00000232388.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.028982579 |
Sensitive |
| ENSG00000233654.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.002078364 |
Sensitive |
| ENSG00000234617.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.02429381 |
Sensitive |
| ENSG00000234684.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.030631328 |
Sensitive |
| ENSG00000234698.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.023101309 |
Sensitive |
| ENSG00000236935.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.044902555 |
Sensitive |
| ENSG00000237899.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.047463072 |
Sensitive |
| ENSG00000237993.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.039905741 |
Sensitive |
| ENSG00000240143.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.011404117 |
Sensitive |
| ENSG00000241520.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.030572124 |
Sensitive |
| ENSG00000243368.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.033590579 |
Sensitive |
| ENSG00000244332.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.037402043 |
Sensitive |
| ENSG00000248367.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.005107653 |
Sensitive |
| ENSG00000250988.3 |
Gemcitabine |
Skin cutaneous melanoma |
0.006215639 |
Sensitive |
| ENSG00000253476.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.024961816 |
Sensitive |
| ENSG00000253961.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.005017534 |
Sensitive |
| ENSG00000254028.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.008305806 |
Sensitive |
| ENSG00000254526.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.009734431 |
Sensitive |
| ENSG00000256196.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.003694711 |
Sensitive |
| ENSG00000256443.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.001595375 |
Sensitive |
| ENSG00000256940.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.005370843 |
Sensitive |
| ENSG00000257809.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.015809262 |
Sensitive |
| ENSG00000258982.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.026581855 |
Sensitive |
| ENSG00000259083.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.034259313 |
Sensitive |
| ENSG00000259201.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.032252061 |
Sensitive |
| ENSG00000259474.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.000258466 |
Sensitive |
| ENSG00000259755.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.001916575 |
Sensitive |
| ENSG00000259894.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.033936733 |
Sensitive |
| ENSG00000260167.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.000585307 |
Sensitive |
| ENSG00000260213.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.00000216 |
Sensitive |
| ENSG00000260260.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.018082728 |
Sensitive |
| ENSG00000260552.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.000122314 |
Sensitive |
| ENSG00000260588.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.039870275 |
Sensitive |
| ENSG00000260647.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.046362148 |
Sensitive |
| ENSG00000260858.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.019814503 |
Sensitive |
| ENSG00000260924.2 |
Gemcitabine |
Skin cutaneous melanoma |
0.0159359 |
Sensitive |
| ENSG00000260986.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.046569741 |
Sensitive |
| ENSG00000261204.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.017451422 |
Sensitive |
| ENSG00000261544.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.035806378 |
Sensitive |
| ENSG00000262703.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.015718214 |
Sensitive |
| ENSG00000263906.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.000820915 |
Sensitive |
| ENSG00000265010.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.01401295 |
Sensitive |
| ENSG00000265334.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.026670656 |
Sensitive |
| ENSG00000266677.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.002011955 |
Sensitive |
| ENSG00000266993.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.007023842 |
Sensitive |
| ENSG00000267248.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.028376216 |
Sensitive |
| ENSG00000268375.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.015705826 |
Sensitive |
| ENSG00000269961.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.027670936 |
Sensitive |
| ENSG00000270100.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.04003994 |
Sensitive |
| ENSG00000270761.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.000254528 |
Sensitive |
| ENSG00000271737.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.017292377 |
Sensitive |
| ENSG00000272158.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.031632285 |
Sensitive |
| ENSG00000272217.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.036982153 |
Sensitive |
| ENSG00000272382.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.013894336 |
Sensitive |
| ENSG00000272660.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.003715275 |
Sensitive |
| ENSG00000272744.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.04728334 |
Sensitive |
| ENSG00000272892.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.030480282 |
Sensitive |
| ENSG00000272933.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.010457895 |
Sensitive |
| ENSG00000272983.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.005895382 |
Sensitive |
| ENSG00000273001.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.006130301 |
Sensitive |
| ENSG00000273305.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.00741706 |
Sensitive |
| ENSG00000273449.1 |
Gemcitabine |
Skin cutaneous melanoma |
0.000482903 |
Sensitive |
| ENSG00000177993.3 |
Gemcitabine |
Thyroid carcinoma |
0.020300424 |
Sensitive |
| ENSG00000223478.1 |
Gemcitabine |
Thyroid carcinoma |
0.002270564 |
Sensitive |
| ENSG00000224660.1 |
Gemcitabine |
Thyroid carcinoma |
0.010751589 |
Sensitive |
| ENSG00000224945.1 |
Gemcitabine |
Thyroid carcinoma |
0.018602354 |
Sensitive |
| ENSG00000226149.1 |
Gemcitabine |
Thyroid carcinoma |
0.03272862 |
Sensitive |
| ENSG00000227477.1 |
Gemcitabine |
Thyroid carcinoma |
0.040355765 |
Sensitive |
| ENSG00000227695.1 |
Gemcitabine |
Thyroid carcinoma |
0.033017152 |
Sensitive |
| ENSG00000228323.2 |
Gemcitabine |
Thyroid carcinoma |
0.003758714 |
Sensitive |
| ENSG00000230068.2 |
Gemcitabine |
Thyroid carcinoma |
0.019986654 |
Sensitive |
| ENSG00000230658.1 |
Gemcitabine |
Thyroid carcinoma |
0.029500558 |
Sensitive |
| ENSG00000231711.2 |
Gemcitabine |
Thyroid carcinoma |
0.006796423 |
Sensitive |
| ENSG00000233330.1 |
Gemcitabine |
Thyroid carcinoma |
0.021334036 |
Sensitive |
| ENSG00000234626.1 |
Gemcitabine |
Thyroid carcinoma |
0.027524574 |
Sensitive |
| ENSG00000235106.4 |
Gemcitabine |
Thyroid carcinoma |
0.038159367 |
Sensitive |
| ENSG00000235904.1 |
Gemcitabine |
Thyroid carcinoma |
0.027340721 |
Sensitive |
| ENSG00000236671.3 |
Gemcitabine |
Thyroid carcinoma |
0.048965727 |
Sensitive |
| ENSG00000237646.1 |
Gemcitabine |
Thyroid carcinoma |
0.040043559 |
Sensitive |
| ENSG00000237914.1 |
Gemcitabine |
Thyroid carcinoma |
0.009822588 |
Sensitive |
| ENSG00000240057.1 |
Gemcitabine |
Thyroid carcinoma |
0.015763637 |
Sensitive |
| ENSG00000243810.1 |
Gemcitabine |
Thyroid carcinoma |
0.036204047 |
Sensitive |
| ENSG00000247970.2 |
Gemcitabine |
Thyroid carcinoma |
0.039958363 |
Sensitive |
| ENSG00000251536.2 |
Gemcitabine |
Thyroid carcinoma |
0.0239479 |
Sensitive |
| ENSG00000254295.1 |
Gemcitabine |
Thyroid carcinoma |
0.003321498 |
Sensitive |
| ENSG00000254433.1 |
Gemcitabine |
Thyroid carcinoma |
0.021662782 |
Sensitive |
| ENSG00000254671.1 |
Gemcitabine |
Thyroid carcinoma |
0.01415598 |
Sensitive |
| ENSG00000255227.1 |
Gemcitabine |
Thyroid carcinoma |
0.031329667 |
Sensitive |
| ENSG00000257671.1 |
Gemcitabine |
Thyroid carcinoma |
0.032130094 |
Sensitive |
| ENSG00000259687.1 |
Gemcitabine |
Thyroid carcinoma |
0.021161516 |
Sensitive |
| ENSG00000259877.1 |
Gemcitabine |
Thyroid carcinoma |
0.045820139 |
Sensitive |
| ENSG00000260277.1 |
Gemcitabine |
Thyroid carcinoma |
0.01241982 |
Sensitive |
| ENSG00000260588.1 |
Gemcitabine |
Thyroid carcinoma |
0.039408932 |
Sensitive |
| ENSG00000260742.1 |
Gemcitabine |
Thyroid carcinoma |
0.035167285 |
Sensitive |
| ENSG00000261341.1 |
Gemcitabine |
Thyroid carcinoma |
0.038497096 |
Sensitive |
| ENSG00000261737.1 |
Gemcitabine |
Thyroid carcinoma |
0.026133 |
Sensitive |
| ENSG00000263618.1 |
Gemcitabine |
Thyroid carcinoma |
0.011517346 |
Sensitive |
| ENSG00000266993.1 |
Gemcitabine |
Thyroid carcinoma |
0.036848715 |
Sensitive |
| ENSG00000270031.1 |
Gemcitabine |
Thyroid carcinoma |
0.014887903 |
Sensitive |
| ENSG00000270102.1 |
Gemcitabine |
Thyroid carcinoma |
0.048959894 |
Sensitive |
| ENSG00000270457.1 |
Gemcitabine |
Thyroid carcinoma |
0.049953799 |
Sensitive |
| ENSG00000271270.1 |
Gemcitabine |
Thyroid carcinoma |
0.038922608 |
Sensitive |
| ENSG00000272142.1 |
Gemcitabine |
Thyroid carcinoma |
0.04838446 |
Sensitive |
| ENSG00000273281.1 |
Gemcitabine |
Thyroid carcinoma |
0.008723873 |
Sensitive |
| ENSG00000273437.1 |
Gemcitabine |
Thyroid carcinoma |
0.019934864 |
Sensitive |
